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NEED FOR CELL SEPARATIONS AND SORTING TECHNOLOGIES
The development of new methods and technologies for cell separation, sorting, selection, 
isolation, or enrichment (many times the aforementioned terms are used interchangeably) are 
becoming more imperative due in part to the wealth of research aimed at addressing issues 
for the analysis of liquid biopsy targets, such as rare cells, to realize the concept of 
“precision medicine”. Precision medicine is defined as “treatments targeted to the needs of 
individual patients on the basis of genetic, biomarker, phenotypic, or psychosocial 
characteristics that distinguish a patient from others with similar clinical presentations.”1 
Before full implementation of precision medicine in a hospital or clinical setting, 
technological discoveries must be realized to assist in the analysis of disease-associated cells 
enriched from complex samples.
Liquid biopsy markers and the cargo that they carry have been shown to be an attractive 
source of information that can be used to facilitate precise decisions for disease 
management. These biomarkers include, but are not limited to, rare cells such as circulating 
tumor cells (CTCs) or cancer stem cells (CSCs), immune cells (i.e., CD8+ T-cells), bacterial 
and viral cells, cell-free molecules such as cell free DNA (cfDNA), and extracellular vesicles 
(EVs). Liquid biopsies are attractive because of the minimally invasive nature of the 
sampling method (i.e., collection of peripheral blood, urine, saliva) to secure relevant 
biomarkers. These biomarkers can enable precision medicine decisions on managing a 
variety of diseases, including oncology and nononcology-related diseases.2,3 Liquid biopsies 
*Corresponding Author: ssoper@ku.edu.
#M.A.W. amd I.M.F. contributed equally.
Notes
The authors declare the following competing financial interest(s): S.A.S. holds equity shares in BioFluidica, Inc., a company that holds 
commercialization rights to CTC isolation technology presented herein. M.A.W. declares a conflict of interest as a spouse of a 
BioFluidica, Inc. employee. I.M.F. declares no conflict on interest.
HHS Public Access
Author manuscript
Anal Chem. Author manuscript; available in PMC 2020 September 03.
Published in final edited form as:













allow for more frequent sampling4 over long periods of time when compared to traditional 
solid tissue biopsies. Therefore, clinical oncology has focused on investigating the ability of 
liquid biopsies to provide equivalent or further information to clinicians than is currently 
received from solid tissue analysis or imaging. The biomarker needs to provide actionable 
information by indicating disease recurrence, progression, or survival to help guide 
treatment decisions.5
As stated, although terms such as cell sorting, separation, enrichment, or isolation are often 
used interchangeably, for clarity we define two types of cell isolation/enrichment processes: 
(i) cell separations (i.e., isolation), which are predicated on the enrichment of cells from 
samples that utilize a batch-type approach. An example here would be affinity-based 
approaches in which target cells are selected from a sample using surface immobilized 
antibodies, aptamers, or peptides. Once the target cells are enriched from the sample, they 
can be either analyzed directly on the surface to which the affinity agent is attached or 
released to allow for subsequent analysis such as molecular profiling.
The second type of cell isolation process is cell sorting, which continuously monitors either 
a physical or biological property of a cell contained in a sample and directs the relevant 
target cells to a receiver. A good example of a cell sorter technology is flow assisted cell 
sorting (FACS) in which cells contained in a biological sample are labeled with a reporter 
and following interrogation online using a laser, are directed into a receiving reservoir for 
analysis. For cell sorting, the identification process of the target cell(s) can be based on a 
physical property of the target cell (i.e., size, density) or biological property (i.e., expression 
of a particular antigen).
Upon inspection of the literature, it became apparent that one of the most reported 
application for cell sorting or separation involves CTCs. Numerous methods and platforms 
have been developed to specifically provide enrichment of CTCs. CTCs are shed from a 
primary tumor or micro/macro-metastatic sites and released into blood circulation initiating 
metastasis in distant organs. These cells are extremely rare or not detected at all in healthy or 
nonmalignant disease.6 Numerous studies have assessed CTCs for clinical use;7,8 a search of 
Web of Science over the period between 2017 and 2019 produced more than 11 000 
publications mentioning “CTC” in their title or in the main text of the article. The review 
presented herein, however, will focus on technologies for the selection of other “low 
abundant” cells, immune cells, or bacterial cells using either separation and/or sorting 
techniques. The reviewed literature highlighted in this review covers the time frame from 
September 2017 to September 2019.
As will be shown in this review, many isolation technologies select cells of interest based on 
biological or physical properties of the target cells to discriminate them from other, more 
abundant red blood cells (RBCs) or white blood cells (WBCs) when blood is the sampling 
milieu. Biological properties for selection can be defined as the expression of a unique 
antigen not expressed in other blood components. In the case of CTCs, new antigens are 
being explored for selection in addition to the well-recognized surface protein, epithelial cell 
adhesion molecule (EpCAM). Technologies employing physical properties, on the other 
hand, seek to discriminate CTCs and other cells based on size, deformability, density, or 
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dielectric properties, among others. Some technologies can exploit a combination of both 
biological and physical properties.
The primary challenge in CTC analysis has been the low abundance of CTCs (1–3 000 
CTCs/mL)9 against a high background of blood cells (109 RBCs/mL; 107 WBCs/mL).10 
CTCs must be discerned by a unique property that specifically differentiates CTCs from 
blood cells to affect favorable selection operational metrics, such as recovery and purity.
It will also become apparent from this review that as precision medicine matures, there is a 
need to not just “enumerate” the markers, such as cells from clinical samples, but also 
analyze their molecular cargo (i.e., DNA, mRNA) to guide treatment decisions, provide 
information as to the best treatment options for a patient, determine if the patient is 
responding to treatment, secure information on disease recurrence, and/or identify bacterial 
cells and their antibacterial resistance. The challenge with liquid biopsy markers in terms of 
their molecular analysis is the mass limits (i.e., nucleic acids copy number) they impose on 
the molecular assay.11 For example, it is not uncommon to detect a single cancer cell (i.e., 
CTC) per mL of blood. Within this 1 CTC there are 2 copies of each chromosome with a 
genomic (g)DNA mass of ~6 pg and about 1 pg of mRNA.12 While amplification of the 
DNA via PCR or reverse transcription of the mRNA followed by PCR can be used to 
increase the copy number of the nucleic acids, issues may arise with amplification bias 
resulting in poor representation of the genome, masking epigenetic modifications, and 
potential false results due to polymerase errors.
We present in this review technologies that addressed these challenges.13,14 We will review 
methods that merge cell enrichment methods with downstream applications such as RNA 
and DNA sequencing.15–18 The difficulties with the analysis of proteins harvested from a 
limited number of selected cells also exists, owing to the limit-of-detection of molecular 
analysis methods used for protein profiling and the lack of techniques for the amplification 
of proteins. Challenges of existing approaches that cannot handle subattomole quantities of 
proteins isolated from minute numbers of cell lysates were addressed by reports highlighted 
in this review.19
In view of the needs and challenges associated with downstream analysis of the molecular 
cargo of enriched cells, we wish to point out that there are metrics that can compare the 
utility of different cell isolation methodologies. These “figures-of-merit” include (i) ability 
to efficiently recover the cell(s) of interest, (ii) aptitude to select high-purity cell populations, 
and (iii) process large samples in a high-throughput fashion to efficiently search for rare 
cells.
Even though CTCs hold a strong presence with respect to isolation and enrichment 
platforms, there are other type of cells for which novel platforms were demonstrated. For 
example, technologies were presented for the screening and analysis of bacterial cells,20–27 
yeast cells,28,29 immune cells,30,31 or characterization of red blood cells.32,33 This review 
will cover methods for cell separation and sorting based on numerous phenomena, such as 
acoustophoresis, affinity, dielectrophoresis and inertial forces, size and elasticity, 
deterministic lateral displacement, flow fractionation, and density gradient centrifugation. 
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We cover in this review magnetic, impedance, and fluorescence-activated cell sorters as well 
as droplet-based methods. A part of this review will also consist of methodologies based on 
image processing for guided particle sorting, such as optofluidic sorters.
CELL SEPARATION METHODS
Affinity and Adhesion-Based Separations.
By utilizing different ligands and substrates, highly specific affinity interactions can be used 
for cell isolation. Commonly used affinity selection methods involve taking advantage of 
specific and strong antibody-antigen interactions, in which particular cells can be targeted by 
examining surface antigens they possess, and functionalizing solid phases, such as a 
microchannel surface or magnetic beads, with an antibody for enrichment of a target cell 
from a sample. Microfluidic devices afford high surface area-to-volume ratios, enabling the 
opportunity for enhanced cell-wall interactions, hence, highly efficient recovery of rare cells. 
As noted previously, these are considered cell separations because the cells are captured by 
the affinity agents in a batch mode and following enrichment can be released from the 
platform.
With affinity-based separations, it is important to understand cell biology because cells are 
not static and can undergo transitions causing down regulation of potential targeting antigens 
used for enrichment of particular cells. For example, EpCAM is well recognized to be 
expressed by cancers of epithelial origin; however, evidence suggests the heterogeneous 
nature of CTCs stems from the epithelial-to-mesenchymal transition (EMT) that produces 
mesenchymal CTCs. An in vitro model of EMT was developed to show that EMT-induction 
decreased EpCAM expression and as a result lower sensitivity of anti-EpCAM based 
recovery of cells. The researchers suggested that for CTC capture, targeting cells with EGFR 
antigens rather than EpCAM may be more robust, specifically in light of EMT, providing 
valuable insight for potential affinity-based separation methods.34
CellSearch utilizes anti-EpCAM-functionalized magnetic beads to isolate CTCs from blood. 
A recently developed microfluidic device utilized a similar magnetic nanoparticle-based 
approach.35 The device stratified CTCs into different on-chip zones using magnetic forces to 
isolate CTCs based on their EpCAM expression levels. Blood was incubated with magnetic 
nanoparticles functionalized with anti-EpCAM antibodies, and targeted cells were 
stoichiometrically labeled with particles according to the number of EpCAM protein 
molecules on their surface. X-shaped structures in a microfluidic device created low-flow 
regions to increase CTC capture in the presence of a magnetic field.35,36 Cells experienced 
lower velocity as they moved through the device with an expanding cross-sectional area. The 
magnetic force applied to the cells was proportional to the amount of nanoparticles bound to 
the EpCAM-expressing cells. Cells with a higher EpCAM expression level experienced 
higher magnetic forces and were trapped in the early zones of the device, whereas cells with 
lower EpCAM expression were trapped in later zones. This microfluidic device was able to 
detect CTCs in 86% of tested clinical patient samples compared to 60% with CellSearch.35
Kang et al.37 demonstrated a dual-immunopatterned (DIP) microfluidic device fabricated for 
the simultaneous capture of both epithelial and mesenchymal CTCs utilizing anti-EpCAM 
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antibodies and newly developed anti-63B6 antibodies (Figure 1A). The DIP device consisted 
of a circular chamber, where an inlet and four outlets were located at the center and the edge 
of the chamber. The chamber was formed by aligning two similarly designed layers each 
with evenly spaced rings and an array of microposts. The rings were alternately formed from 
the upper and bottom layers having a different antibody coated and spaced 135 μm apart 
ultimately forming four zones consisting of 20 rings each. The device also contained zones 
with differing pressure under steady flow rates, which allowed for the profiling of CTCs 
based on surface protein expression levels. A recovery of 95% was reported.
Dasanna et al.38 simulated the effects of shear rates and inclination angles of P-selectin 
adhesive stripes in a microfluidic device to investigate the enrichment of WBCs from RBCs. 
Interplay between microscopic bond dynamics from leukocytes sticking to the adhesive 
stripes and macroscopic determinants such as shear rate and viscosity afforded dynamic 
states such as free flow, rolling, and transient adhesion. The relationship between these states 
were in good agreement with experimental results for the isolation of WBCs from whole 
blood on P-selectin patterned chips. Additionally, the authors used the simulations to 
investigate the separation of three different stages of malaria-infected RBCs.
Inspired by the nonfouling nature of the outer membrane of RBCs, Li et al.39 synthesized 
copolymer micelles with RBCs’ cell outer membrane and zwitterion interface. The so-called 
cell membrane mimetic micelles demonstrated lack of bioadhesion in the body; however, 
when modified with folic acid (FA) and an arginine-glycine-aspartic acid (RGD) peptide, 
they exhibited affinity for folate receptor (FR) overexpressed on tumor cells (Figure 1B,C). 
Cell membrane mimetic surfaces (CMMS) repelled blood cells at >99.999%, while targeting 
CTCs via ligands tethered to the surface to enable cancer cell capture provided 91% 
recovery and 89% purity.39
A recent paper by Chen et al.40 showed that lateral filter array microfluidics (LFAM) and 
immunoaffinity can be combined into one device to accomplish CTC isolation from buffer-
diluted blood. The device captured spiked in model CTCs and clinical CTCs with and 
without antibody functionalization. The array had five zones of lateral filters for a total of 13 
600 filters with sizes between 6 and 10 μm. The filters were fabricated in a parking-space-
like arrangement, which allowed automatic flow adjustment if a filter space was occupied by 
a CTC. Simulations were performed to find the optimal flow rate at which fluid passed 
through every array. Without functionalization, capture efficiency of a pancreatic cancer cell 
line varied between 70 and 84%. With anti-EpCAM functionalization, capture efficiency 
improved to 99% at a flow rate of 1.8 mL/h, with low nonspecific binding of WBCs.
A flow-based microfluidic device was developed by Birmingham et al.43 to investigate 
metastasis via adhesion separation. Cells were perfused over a microfluidic channel bed 
functionalized with E-selectin. Residence time was used as a measure for cellular adhesive 
behavior to separate cells into two discrete fractions: adhesive and free-flowing. The device 
demonstrated that increased adhesion correlated with enhanced metastatic potential in 
LS174T colon carcinoma cells, affording the opportunity to better understand cancer 
metastasis.43
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A microfluidic device with anti-EpCAM and anti-CD133 antibodies functionalized to its 
surface was utilized to isolate epithelial CTCs and those with cancer stemlike characteristics 
(CSCs) from pancreatic ductal adenocarcinoma (PDAC) patient blood samples. It was 
discovered that 84% of patients had detectable levels of EpCAM(+) CTCs, while CD133(+), 
indicative of CSC character, were detected in 7 out of 10 patients.44 Zeinali et al.41 also 
utilized both anti-EpCAM and anti-CD133 antibodies to isolate subpopulations of CTCs 
from the peripheral blood of PDAC patients. The CTC Carpet Chip contained ~80 000 
microposts and enabled >97% recovery of cancer cells spiked into whole blood with 76% 
purity (Figure 1D,E).
Sinusoidal microfluidic devices42 were used for the affinity selection of circulating plasma 
cells (CPCs) from patients diagnosed with plasma cells disorders (Figure 1F), such as 
multiple myeloma. Using anti-CD138 antibodies covalently attached to the sinusoidal 
microfluidic chip’s surfaces, CPCs from blood of patients diagnosed with monoclonal 
gammopathy of undetermined significance (MGUS), symptomatic or active multiple 
myeloma were recovered with 70% efficiency. The isolated CPCs were then assessed for 
KRAS mutations using polymerase chain reaction (PCR), ligase detection reaction (LDR), 
and capillary gel electrophoresis (CGE) and tested for chromosomal abnormalities via 
fluorescence in situ hybridization (FISH).
Kim et al.45 used graphene oxide as a substrate material for antibody surface conjugation, as 
it affords a high density of surface-functionalized antibodies, making a microfluidic device 
capable of detecting low numbers of CTCs from blood (73 ± 32% at 3–5 cells/mL blood; 
87% for 100 spiked cells/mL). The device was able to detect at least 1 CTC/mL in 89% of 
metastatic breast cancer patients. Captured CTCs were analyzed using immunofluorescence 
and transcriptional analysis.
Aptamers were shown as affinity capture agents in work by Reinholt et al.46 The cell-capture 
microchannel was functionalized with aptamers and cells were directed toward a micropillar 
array to enhance CTC capture. By performing cell capture and lysis on one device, sample 
loss and contamination were significantly reduced. Sample was first flowed toward the CTC 
capture array for cell separation. After separation, the flow direction was changed 
orthogonal to the capture array and lysis buffer was introduced into the chip. Captured cells 
were lysed and their contents flowed toward a second array for the physical entanglement of 
gDNA. After entanglement, gDNA was amplified and prepared for the identification of point 
mutations.
Field-effect transistors (FETs) can be useful biosensors for cellular detection. Chen et al.47 
was able to integrate high-specificity aptamer-functionalized FETs with cell trapping devices 
in order to affinity capture cancer cells for enumeration with an automated process on a 
microfluidic device at a flow rate of 90 μL/min.
In an effort to improve on CTC isolation, many studies utilized negative selection to enrich 
CTCs. Negative selection is performed by targeting leukocytes with anti-CD45 antibodies to 
deplete WBCs. This CTC isolation method reported by Liao et al.,48 who integrated negative 
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CTC selection with subsequent spheroid cell culture to increase cancer cell purity up to 
34%, compared to <10% for other negative affinity-based methods.48
Release of captured cells are an important part of any CTC separation assay, which uses a 
batch type approach to enrich cells from a mixed population. A recent development for 
enriched cell release has been made that utilized affinity capture with antibodies conjugated 
to a photodegradable poly(ethylene glycol), PEG, hydrogel cell capture surface. Cells were 
captured with an efficiency of 13.4% from whole blood and were selectively released from 
the surface by irradiation with UV light allowing for bulk or individually targeted release 
from the surface while maintaining viability above 90%.49
SORTING METHODS
Acoustofluidic- and Acoustophoretic Cell Sorting.
Acoustofluidics employ ultrasonic waves generated by interdigitated transducers (IDTs) on a 
piezoelectric material that is integrated to a microfluidic device. These waves can propagate 
into a fluid in the form of surface acoustic waves (SAWs) creating different inertial and fluid 
velocities.50 Several new microfluidic designs have been recently developed that take 
advantage of acoustofluidics for cell sorting.
A new design introduced by Wu et al.51 used tilted-angle SAWs and provided significant 
improvement in the throughput of the acoustic sorting method (Figure 2A). The design 
increased acoustic energy density by using a hybrid PDMS-glass channel, while 
simultaneously increasing CTC sorting efficiency to 86% at a throughput of 7.5 mL/h. The 
device isolated CTCs from clinical prostate cancer patient blood, which were subsequently 
immunophenotyped for confirmation of CTC isolation. The device also contained a PDMS 
divider present within a microchannel. In a straight channel, the velocity distribution is 
parabolic, but with this PDMS divider, the velocity of cells in the center of the channel was 
lower than those toward the walls. This velocity decrease afforded more time for the acoustic 
radiation forces to act upon cells, which allowed for better differentiation between CTCs and 
WBCs due to lateral displacement.
The same research group reported throughput for a single, enclosed microfluidic device at 
500 μL/min achieving simultaneous sorting of 10, 12, and 15 μm particles. At ~85% purity, 
WBCs were sorted from RBCs and CTCs from WBCs utilizing novel three-dimensional 
acoustofluidic tweezers (3D-AFT) (Figure 2B). The 3D-AFT balanced fluidic drag forces 
with acoustic radiation to achieve particle/cell focusing in three dimensions. Particles were 
first directed into an asymmetric serpentine channel, where lift forces were dominant and 
aligned particles/cells into a single lateral stream. To accomplish alignment in the vertical 
direction, an acoustic focusing resonator was implemented to create pressure nodes that 
vertically align particles/cells. The size of the particle or cell along with the input power 
determined the deflection distance, which could be exploited for sorting.52
Gnyanwali et al.53 combined both ultrahigh frequency ultrasound (US) backscatter and 
laser-induced photoacoustic (PA) waves to accomplish a high throughput label-free analysis 
of single cells with a microfluidic device. US backscatter results from an acoustic impedance 
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differential between a cell and the surrounding medium, while PA waves are generated from 
optical absorption of the cell creating a rapid thermo-elastic expansion that caused 
broadband mechanical waves at ultrahigh frequency. The US transducer was integrated to a 
PDMS microfluidic device and was triggered simultaneously with a laser. The laser excited 
the particle first, generating a PA wave, and ~900 ns later, a US pulse scattered off the 
particle or cell. Particles/cells could be differentiated by their generated backscatter and/or 
PA waves. RBCs, for example, absorb light at 532 nm and generate a strong PA signal. The 
device (Figure 2C) could identify and count RBCs and WBCs at a throughput of 150 
cells/min similarly to a conventional fluorescence-activated cell sorting (FACS) system 
without the adverse effects of buffers required for RBC lysis, which can alter membrane 
permeability.
By combining IDTs and focused IDTs (FIDTs) to produce both standing surface acoustic 
waves (SSAWs) and traveling surface acoustic waves (TSAWs) (Figure 2D,E), Wang et al.54 
recovered 90% of glioma cells from blood. SSAWs were produced from the interference of 
SAWs propagating in opposite directions. These SSAWs have a one-dimensional periodic 
distribution of pressure nodes and antinodes. Particles and cells can be trapped at these 
pressure nodes, which can be used to align particles/cells into lines. The SSAWs act as a 
focusing module for the particles or cells without need for a sheath flow. The FIDTs produce 
TSAWs to push tumor cells away from RBCs. The energy of TSAWs is concentrated at a 
focal point with high spatial resolution, and particles or cells will experience a size-
dependent unidirectional force in an acoustic traveling wave field, which pushes particles or 
cells along the direction of TSAW propagation. Wang et al. also demonstrated sorting of 5 
μm diameter and 2 μm diameter particles using the same device.54
In a study reported by Gonzalez et al.,6 a new strategy of utilizing plate acoustic waves 
(PAW) was demonstrated in a report that sorted tumor cells from WBCs in a microfluidic 
device with approximately 84% recovery and 80% purity. The device was actuated by plate 
vibrations from a single SU-8 based piezoelectric transducer, allowing the opportunity to 
utilize lower operating frequencies and lower manufacturing costs compared to traditional 
bulk acoustic wave devices, and also overcame physical restrictions of IDTs. This chip-
based sorting relied on the generation of typical vibration modes of a plate that generated 
pressure nodes within the microfluidic channel at desired locations. The geometry of the 
chip gave a large surface/volume ratio and, together with the thickness being slightly smaller 
than a quarter of the generated wavelength, provided the platelike actuation of the plastic 
device.56
Garg et al.57 reported on Lateral Cavity Acoustic Transducers (LCATs), which utilized 
trapped bubbles that acted as acoustic microstreaming sources. The oscillation of the 
bubbles was accomplished by an acoustic energy source allowing LCATs to simultaneously 
accomplish bulk pumping and size-based sorting of particles in solution for the sorting of 
platelets, RBCs, and WBCs. Rapid on-chip immunolabeling was done to verify captured cell 
identity; the device generated ~100% efficiency with a 200× enrichment ratio from a 20 μL 
sample.
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The work of Shamloo et al.58,59 presented a considerable amount of simulation and 
modeling in an effort to optimize design specifications for efficient sorting of various blood 
particles in both rectangular and trapezoidal acoustofluidic devices. Applied voltage 
simulations were performed to determine a voltage domain in which the cells could be 
sorted with maximum efficiency. Numerical studies of SSAWs should be considered in the 
future for IDT geometrical factors, channel geometry, or tilted angle waves to analyze the 
sorting process.
Acoustophoresis is emerging as a highly promising technique for cell sorting. One work 
utilized size-independent acoustic impedance to sort CTC model cells (i.e., cell lines) from 
peripheral blood mononuclear cells (PBMCs) in 1 h with >86% recovery and >50-fold 
enrichment. This was accomplished by infusing two fluids into a channel, a suspending 
medium with an acoustic impedance matching that of PBMCs and a sheath fluid with a 
higher or lower impedance than that of CTCs. Depending on their impedance, CTCs were 
able to migrate into the higher or lower impedance fluid (Figure 2F).55
Affinity size amplifiers were presented by Liu et al.60 to improve sorting efficiency via 
acoustofluidics. Gelatin-coated 40 μm SiO2 microbeads were grafted with an anti-EpCAM 
antibody containing gel, allowing for selective affinity capture of CTCs. The microfluidic 
device then used TSAWs to sort the affinity-captured CTCs from normal blood cells based 
on size-dependent responses to the administered acoustic waves. Recoveries of 77% and 
purities of 96% were reported. Captured CTCs were released (96% efficiency, 83% viability) 
from the microbeads via degradation of the gelatin coating for downstream analysis.
TSAWs have been combined with inertial flow focusing for a microfluidic device that was 
able to generate high purity (>90%) and viability (>90%) while sorting cells at rates 
comparable to conventional FACS instruments. Inertial flow focusing is used to order the 
cells into a single file, while a laser interrogates cells for fluorescent signals at the output 
and sorts cells via IDT-generated TSAWs at rates up to 5 000 events per second. Sorting 
experiments in an injection buffer similar to cell culture media involved staining 10% of 
infused cells with calcein AM as a fluorescent label and were sorted from nonlabeled cells.
61
Coupling of μFACS with SSAWs was demonstrated by Ren et al.,62 who were able to sort 
mammalian cells with >90% purity at 2 500 cells/s. A single-layer microfluidic device 
integrated an in-plane optical fiber detector and two separate IDTs, one for cell focusing and 
the other for cell deflection. Cells were first focused, then analyzed by the optical fiber 
system, and subsequently deflected into collection or waste receiver wells.
Inertial and Lift-Force Cell Sorting.
Inertial microfluidic devices allow for the principles of inertial migration and Dean Flow to 
be exploited. High flow rates can be achieved that afford precise methods for cellular 
sorting. A common method for inertial sorting involves the use of spiral microchannels, and 
many groups have taken to its utilization.
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Lee et al.63 used a spiral channel to sort mesenchymal stem cells from mouse bone marrow 
with a recovery of 73% at a flow rate of 1.6 mL/min. The sorting resulted in the integrity of 
the cells being preserved, retaining high viability (>95%) and maintaining their phenotype 
compared to nonprocessed cells. Kwon et al.64 utilized spiral inertial microfluidics to sort 
viable from nonviable cells. Spiral microfluidic assays for label-less sorting of cells 
demonstrated up to 28% dead cell removal efficiency and ~99% live cell retention efficiency, 
despite the size overlap between viable and nonviable Chinese hamster ovary cells. By 
multiplexing the device to four spirals, the device was able to achieve the removal of small 
nonviable cells at cell concentrations of 10 million cells/mL with a throughput of 6–8 mL/
min.
Another example was demonstrated for the isolation and detection of exfoliated bladder 
cancer cells (EBCCs) from urine samples with inertial focusing microfluidics, which 
afforded 93% sensitivity. Isolated cells were further analyzed downstream and confirmed for 
the presence of EBCCs.65 Spiral inertial microfluidics were also utilized to sort full 
thickness chondrocytes into superficial, middle, and deep zone chondrocyte subpopulations 
based on size and enabled enrichment for potential clinical use for chondrocyte 
implantation.66
Tay et al.47 exploited the fluid mechanics of spiral devices to afford size sorting of PBMCs 
into monocytes, lymphocytes, and platelets with a purity of ~90% in a rapid (130 μL/min), 
continuous, and label-free manner. A study investigated the ability of spiral inertial focusing 
to sort fungal cells from WBCs after RBC lysis. Recovery of 8.4% for spiked fungal cells at 
400 μL/min was demonstrated, showing that inertial spiral focusing could have clinical 
significance as a qualitative device for quickly assessing the presence of fungal cells in 
blood.67
Syverud et al.68 developed a device deemed “Labyrinth”, containing 11 loops and 56 corners 
to sort individual streams of cells with differing sizes at a throughput of 1.8–2.5 mL/min. 
The Labyrinth utilized inertial forces as a focusing element for particles, while drag forces 
from Dean flow enabled particle migration away from the center of a channel. The major 
difference between the Labyrinth and similar devices is that the Labyrinth design employs 
numerous sharp corners placed across the flow pattern. The idea is that these corners are 
“sharper” than traditional loops, enabling the enhancement of Dean forces to migrate 
particles toward their equilibrium positions. This device was able to sort skeletal muscle 
satellite mouse and rat cells from fibroblasts with purities up to 78%. Cells were then 
cultured for 2 weeks to assess structural development. A microfluidic device allowed for the 
sorting of CTCs followed by single-cell isolation. The technique combines two chips, one to 
utilize inertial microfluidics for sorting CTCs from blood, followed by a second chip for 
hydrodynamic focusing to trap single cells. The device was able to process 7.5 mL of blood 
in under 45 min with >90% CTC isolation efficiency.69
Hazra et al.70 developed a device that utilized lift forces from the interfacial tension of a 
liquid-liquid interface to enable label-free sorting at a low Reynolds number (Re < 1) based 
on size and stiffness of cancer cells. Aqueous dextran and PEG were infused into the device 
to form a stable interface. Particles present in either phase experience different noninertial 
Witek et al. Page 10













lift forces due to deformation in the flow field, interfacial tension force at the interface, and 
viscoelastic lift force. The device operated in the Stokes regime, where deformable objects 
experience noninertial lift. The magnitude of this force depended on the particle location 
with respect to the wall. Because noninertial lift force is a function of deformability of the 
object, similarly sized objects of differing elasticity can be sorted. Essentially, the 
competition between noninertial lift force and interfacial tension drive cellular migration and 
therefore sorting. Breast cancer cell lines MCF-7 and MDA-MB-231 were sorted from 
PBMCs in the two-phase system at >25 000 cells/min and ~99% sorting efficiency while 
maintaining viability suitable for culture. In another study, the combined effects of shear-
gradient lift and wall-effect lift forces were used to sort hydrogel droplets by size across 
fluid streamlines. Close to the inlet, randomly distributed hydrogel droplets exist in different 
sizes. As droplets migrate toward the outlet, they migrate to two equilibrium positions along 
the microchannel due to the balance of shear-gradient and wall-effect lift forces; larger 
droplets migrate toward the center of the channel and droplets exit outlet channels in a size-
based manner due to differences in lateral equilibrium positions. Researchers monitored the 
growth of microalgal cells in these droplets to passively sort empty droplets from cell-laden 
droplets with 93.6% purity.71
Bleilevans et al.72 combined hydrodynamic lift forces with flow focusing in a microfluidic 
to sort platelets from RBCs in whole blood. The sorting chip reduced 57% of baseline 
platelet count at a maximum flow rate of 80 μL/h. Researchers hypothesized that 
microfluidic cell sorting can be a useful strategy for platelet bypassing in clinical assays in 
which thrombus formation must be limited. High-Reynolds inertial focusing is used to push 
large particles to the concave edge of curved channels due to opposing shear-induced lift 
forces. In microfluidic devices, this phenomenon can afford high flow rates that can 
eliminate clogging issues and increase throughput.
Keinan et al.28 combined this mechanism of inertial focusing with peripheral Dean vortices 
to isolate 107 yeast cells/min from yeast suspensions based on size differences of 1.5 μm. 
The platform provided the ability to isolate large quantities of microorganisms for proteomic 
and metabolomic analyses. Opposing shear-induced forces that push large particles toward 
the concave side of curved channels, along with superimposed effects of Dean vortices that 
confine small particles to the center of the channel due to rotation induced lift forces allowed 
for particle sorting.
Deng et al.73 developed a microfluidic device to sort living eukaryotic and bacterial cells 
from one another via a flow velocity gradient. This was accomplished using a low velocity 
sheath flow with high viscosity near the wall of the channel and a high velocity sheath flow 
with a low viscosity on the other side of the sample flow. This device was able to sort 1.0 
and 9.9 μm particles with 99% efficiency and isolate 94% of live bacteria.
Pritchard et al.74 reported a technique that utilized vortex-actuated cell sorting (VACS) to 
deflect individual cells by generating a temporary microfluidic inertial vortex with the aid of 
a thermal vapor bubble. The concept of VACS was accomplished by placing a sharp edge in 
a microchannel of ~100 μm dimension coupled with transient flow caused by microbubble 
expansion and collapse, which can lead to localized inertial rotation causing particle 
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deflection. This mechanism can sort cells based on fluorescently labeled biomarkers with 
recoveries ranging from 72 to 97%. Using a unique, wavy design for inertial particle 
focusing, Zhou et al.75 were able to focus particles as small as 3 μm by producing 
periodically reversed Dean secondary flow along the microchannel cross sections. This 
sheathless microfluidic device operated at a continuous flow rate of ~200 μL/min and 
utilized sharp turns (waves) that create a mismatch in lateral centrifugal forces between a 
continuous flow in the center and near-wall regions and through conservation of mass and 
generates two counter-rotating Dean vortices along the channel. The simultaneous effect of 
the Dean drag force and net inertial lift forces resulted in distinct equilibrium positions of 
differently sized cells, enabling size-based inertial sorting. The design was able to recover 
~90% of spiked breast cancer MCF-7 cells in a diluted blood sample with a purity between 
5.3 and 69% while maintaining cell viability.
Hymel et al.57 reported on simulating the effects of cell size, cytoplasm viscoelasticity, flow 
rate, and bifurcation angle on sorting distance for blood cells and CTCs in bifurcating 
microchannels with inertial flow mechanics. The study suggested altering the bifurcation 
angle can increase sorting efficiency.
Vortex technology for CTC isolation is grounded on inertial microfluidics and laminar 
microscale vortices.76 Cells are sorted based on size and deformability on a platform 
typically employing a polydimethylsiloxane (PDMS) device. Lemaire et al.76 recognized in 
a recent publication the challenges associated with commercialization efforts of transferring 
technology from a research setting into the market. The authors in particular discussed the 
challenges of PDMS-based microfluidic chips in comparison to thermoplastics. The study 
compared performance metrics for CTCs isolation using PDMS and poly(methyl 
methacrylate), PMMA, devices. Owing to PDMS properties, significant deformation of 
fluidic features even under low pressure was observed (66% vertical deformation) resulting 
in negatively impacted cell capture and isolation metrics. Cell sorting characteristics such as 
recovery, purity, and reproducibility were improved in thermoplastics. It is important to note 
that the authors concluded that a new material required not only optimization but may 
require product redesign.
Deterministic Lateral Displacement and Density Gradient Centrifugation Cell Sorting.
Flow of particles or cells in a deterministic lateral displacement (DLD) array is influenced 
by both the fluidic forces and created obstacles (i.e., pillars). When particles or cells are 
located in the gap between pillars, one with a radius smaller than the width of the streamline, 
will follow the initial streamline and travel in the so-called “zigzag” mode, while the particle 
larger than the first streamline width will be bumped by the pillar and displaced laterally to 
the next streamline. The cutoff size parameter between the zigzag and displacement mode is 
known as the DLD critical diameter (Dc). Particles smaller and larger than Dc will be sorted 
along the length of a DLD device.
Chien et al.77 reported modeling studies of a DLD device that employed mesoscopic 
hydrodynamics of RBCs in DLD devices with circular posts to better understand the 
interplay between cell behavior in complex microfluidic flow environments and sorting 
capabilities of such devices. The authors identified regimes of RBC dynamics (e.g., 
Witek et al. Page 12













tumbling, tank-treading, and trilobe motion) and presented mode diagrams of RBC behavior 
(e.g., displacement, zig-zagging, and intermediate modes) while residing in the DLD device.
A two-stage device that coupled spiral inertial microfluidics and DLD was developed to sort 
7 and 15 μm particles with 100% efficiency. The device demonstrated 91% recovery and 
18% purity when analyzing spiked tumor cells in blood.78
CTC isolation was reported by Wang et al.,79 who integrated DLD microfluidic structures 
with magnetic-activated cell sorting to provide negative selection of WBCs. The device used 
diluted blood samples, operated at sample and buffer flow rates of 60 μL/min and 100 μL/
min, respectively, and yielded a recovery of 85%. Even though the device provided 57× 
enrichment of CTCs over WBCs, the purity of the isolated fractions was low (removal 
efficiency of WBCs was 98.5%, meaning that in 1 mL of blood analyzed, there were ~75 
000 WBCs).
DLD was used for the sorting and isolation of platelet-covered CTCs in the work by Jiang et 
al.80 The authors considered platelets as a cell-surface marker for the isolation of platelet-
masked CTCs from patient peripheral blood. The assay implemented a two-step microfluidic 
strategy to first deplete size-based free platelets using DLD, and in the second step, isolated 
EpCAM(+) CTCs covered by platelets using the herringbone CTC chip that was 
functionalized with antibodies to human platelet antigens (CD41 antibody) and EpCAM 
antigens. Depletion of platelets prior to CTC isolation was critical for the assay, however, 
even with the free platelets depleted, a low purity of isolated CTCs was observed. A 
significant number of WBCs were isolated on the CD41 mAb modified chip (~105 /mL), 
compared to the conventional EpCAM HB-chip (~104 /mL) due to the presence of platelet-
covered WBCs.
Gomis et al.81 designed a DLD device to enhance cell-sorting resolution. The device 
implemented four DLD arrays with successively smaller critical diameters so cells can be 
fractioned into five distinct populations. Using multiple array regions and notched 
microstructures promoting cell tumbling, the device performed sorting of ciliary epithelium 
cells with minimal distribution overlaps between cell types. In particular, the authors 
characterized size distribution of retinal stem cells (RSCs), which were considered as 
candidates for patient-derived cell therapy to repair eye damage to determine if these cells 
could be distinguished from other populations of the ciliary epithelium cells based 
exclusively on size. While the majority of RSCs collected had diameters of 9.4 μm, the 
enrichment of this population was low (~0.5%). Cell recovery and cell viability, however, 
was 80%, significantly higher when compared to fluorescence activated cell sorting (Figure 
3A).
To further improve on the resolution of DLD, Xavier et al.82 designed devices with different 
critical diameters for the isolation of skeletal stem cells (SSCs) from bone marrow. SSCs can 
be potentially used in bone regenerative therapies. Different DLD designs were evaluated for 
sorting based on size and rigidity of the cells as the authors discovered in their previous 
work that SSCs are stiffer than the three main WBC populations present in bone marrow. 
Designed DLDs included (i) a device that used sheath flow to hydrodynamically focus the 
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sample in a narrow stream keeping cells away from the channel walls; (ii) a sheathless 
device, which leads to higher throughput and allowed device operation with a single input; 
and (iii) a device that combined the principles from the aforementioned two designs using 
sheath flow and a mirrored micropillar array to achieve sorting using one section of a single 
Dc. No device provided significant enrichment due to deformation of WBCs to diameters 
below Dc; however, the larger cells showed an increase in capacity to form clonogenic 
cultures indicative of stem cell potential (Figure 3B).
Strachan et al.83 developed a microfluidic device for the isolation of leukocytes based on a 
controlled incremental filtration (CIF) device that can operate with gravity to drive flow 
(Figure 3C–E). Blood cells that have an effective size greater than the threshold critical 
diameter of the device were retained in its central channel, whereas cells less than the cutoff 
size were able to be pulled into the side (i.e., filtrate channels) by the flow of fluid out of the 
central channel at each filtration point. The device could carry out leukaphoresis in three 
modes: (i) infusing blood from a syringe pump, (ii) hanging a bag containing sample 5 feet 
above the device, or (iii) compressing the hanging sample bag with a standard infusion cuff. 
The hand inflated infusion cuff that drove the sample processing delivered a flow rate of 15 
mL/min; hence, a 200 mL leukaphoresis sample can be processed in <15 min. The 
microfluidic for the concentration of leukocytes was compared to conventional density 
gradient centrifugation. Paired samples showed a higher recovery of cells when the 
microfluidic device was used. Enriched T-cell fractions grew at a higher rate in culture than 
the gradient-isolated cells. Proposed benefits of the device included high-throughput, 
simplicity, low cost, and maintenance of sterility of the sample, which would be of great 
value in manufacturing CAR T-cells following isolation via cell cultures.
Sun et al.85 reported a microfluidic density gradient technology that could be beneficial in 
research relying on mononuclear and polymorphonuclear cells isolation. The authors 
designed a flow-through microfluidic to provide PBMCs sorting from whole blood at low-
stress conditions. A density gradient was realized by layering blood over a stream of Ficoll 
using laminar flow characteristics observed in microfluidics.
The work by Fachin et al.84 involved CTC isolation using DLD (Figure 3F,G). The device 
consisted of five microfluidic stages: DLD, first inertial focusing stage, first magnetically 
activated cell sorting (MACS), another inertial focusing stage, and last another MACS. DLD 
consisted of a monolithic chip with 128 multiplexed deterministic lateral displacement 
devices containing ~1.5 million microfabricated features (12 μm–50 μm) used to first deplete 
RBCs and platelets. The outputs from this device were serially integrated with an inertial 
focusing system to align nucleated cells using a shear gradient lift force, a wall interaction 
force, and a Dean flow to remove magnetically labeled CD45, CD16, and CD66b WBCs. 
Inertial focusing and MACS were repeated to provide increased efficiency of the negative 
selection process. Unlabeled cells (i.e., CTCs) were not affected by the MACS stages and 
were collected at the output. This device for antigen independent isolation achieved 99.5% 
recovery of CTCs, with a median of 445 WBCs per mL of input blood.
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Magnetic, Magnetotactic, and Magnetoresistance Cell Sorting Strategies.
Bioanalytical systems that employ magnetic forces to isolate cells have proven useful in 
numerous applications. The magnetic tags, such as micro- or nanoparticles coated with 
antibodies, both polyclonal and monoclonal are widely available and can be easily 
manipulated with the aid of a magnet. A vast number of reports have utilized magnetic, 
magnetotactic, or magnetoresistance methods for the development of cell sorting strategies.
Yu et al.86 demonstrated a system with a magnetic separator and acoustic microfluidic 
focusing to enrich rare cells along with fluorescent activated cell sorting (FACS) and single-
cell sequencing. This system analyzed, isolated, and sorted single cells directly into 
multiwell plates for molecular indexing and transcriptional profiling of single cells. The 
authors reported a proof-of-concept experiment with model cell lines spiked into peripheral 
blood that demonstrated a rapid one-step process to isolate rare cancer cells from lysed 
whole blood. The system provided efficient recovery of cells (92%) compared to the 55% 
recovery achieved by employing a traditional benchtop processing pipeline. Also, gene 
expression analysis at the single-cell level with typical cell-type dependent expression 
signatures for tested cell models was demonstrated.
Tay et al.87 described a magnetic microfluidic for isolation of magnetotactic bacteria (MTB) 
and the estimation of magnetic content in live MTBs. MTBs produce membranous structures 
that contain iron-rich magnetic particles enclosed within a lipid bilayer membrane. These 
features, called magnetosomes, have homogeneous sizes, shapes, and magnetic properties; 
there is interest in using MTBs as “factories” for magnetic nanoparticle production. This 
microfluidic platform could enrich MTBs without compromising their proliferation rate and 
biomineralization ability. The high-throughput format processed 25 000 cells/min.
Murray et al.30 discussed an automated platform for processing rare antigen specific immune 
cells from blood cell samples. The method utilized a magnetic technology that employed 
arrays of ferromagnetically soft micropillars to isolate low-abundance immune cells that 
were prelabeled with magnetic beads. Using high-force magnetic ratcheting (MR), the 
system required no external fluidic handling system. Instead, the target cells were 
automatically extracted from clinical samples and processed using discrete magnetically 
driven displacements across the device. The MR system used an unsupervised mechatronic 
device that generated a cycling magnetic field capable of deterministic displacement and 
processing of individual cells. The authors demonstrated unsupervised collection of several 
immune cell types and automated postextraction culture and processing of these cells. 
Processing of cells at specific locations within the device, including propagation in-place, 
cytokine secretion analysis, nucleic acid purification, and RNA sequencing analysis was 
demonstrated (Figure 4A).
Molecular analysis following magnetic actuation was presented by Ng et al.17 This group 
reported a single-stream Drop-seq method called microfluidic antigen-TCR engagement 
sequencing (MATE-seq) for screening of barcoded nanoparticles (pNPs) against CD8+ T 
cells (Figure 4B). Innovations presented in this work touched on NPs providing a modular 
platform to streamline multiplexing by mixing combinations of primers and binding reagents 
on the same substrate. Also, the integration of DLD and droplet encapsulation enabled 
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purified pNP-labeled T cells to be enclosed within droplets for nucleic acid amplification. 
On-chip operation included purifying the pNP-labeled T cells from free pNPs, entrainment 
of those cells into a droplet-generating microfluidic circuit, and in-droplet RT-PCR. The 
methodology required several advances to integrate multiple functions onto a single 
microfluidic chip and optimization of droplet chemistry for improved stability and efficiency 
during thermal cycles. The authors utilized the MATE-seq to analyze rare, virus-antigen 
specific CD8+ T cells.
Kokkinis et al.88 presented a microfluidic quantification platform for magnetically labeled 
cancer cells. The design combined isolation of magnetically tagged cancer cells from 
unconjugated particles utilizing giant magnetoresistance (GMR) integrated sensors (Figure 
4C). The chip consisted of a channel with integrated conducting microstructures, 
conductors, a quantification area with GMR sensors, and storage chambers. Operations on 
the chip were performed under no flow conditions with the channels filled with capillary 
forces eliminating the need for pumps. The innovative aspect of this method was the induced 
velocity on the magnetic particles and magnetic particles conjugated to cancer cells. While 
the same magnetic field gradient was applied, it was inversely proportional to the volume of 
a moiety, meaning cells not associated with a magnetic tag travel faster, thus sorting 
themselves from those attached to cancer cells. While proof-of-concept was demonstrated 
with cell lines, this chip was not designed for isolating CTCs from blood in its current 
format.
Chen et al.90 designed a magnet-deformability hybrid integrated microfluidic chip for the 
enumeration of CTCs. Arrays of narrow gaps between microellipse posts were designed to 
capture CTCs bonded with immunomagnetic beads. The filter allowed small cells to transit 
through the constriction but blocked the passage of larger or less deformable cells. Multiple 
rows of elliptical micropillars were designed in the chip with the gap width gradually 
decreasing at each row. The hybrid chip delivered high capture efficiency (>90%) even at a 
high flow rate.
Ghuman et al.20 described a bacteriophage-modified magnetic particle-based microfluidic 
device for effective isolation of target bacteria from food samples. The use of phage-
modified magnetic particles in a magnetophoretic microfluidic cell sorting device allowed 
for highly sensitive enrichment and subsequent detection of pathogenic bacteria. Huang et 
al.91 designed a device to address the distribution of magnetic fields. The authors reported a 
microwell device for immunomagnetic single-cell trapping. The addition of a microwell 
layer between the microchannel and magnet produced uniform magnetic fields along the 
device. By introducing a “sweeping” loading protocol to expand the single-particle trapping 
range, process efficiency of 62% and purity of 99% was achieved. Sample processing was 
completed in 10 min and was demonstrated with cell lines.
Kye et al.89 reported a microfuidic device with dual-neodymium magnet-based negative 
magnetophoresis for the size-dependent sorting of microparticles and cells using non-
Newtonian viscoelastic polyethylene oxide (PEO) solution and ferrofluid. PEO solution 
increased the viscoelasticity of the medium, which assisted in sorting microparticles in the 
microfuidic device at low flow rates (7 μL/min) (Figure 4D).
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A concept presented by Oh et al.24 used a magnetizable micropipet tip for MACS (named 
“MACS Tip”) that enabled high-throughput and high-gradient magnetic isolation of cells via 
sample pipetting, which was constructed from a regular 1 mL pipet tip (Figure 4E). It was 
fabricated with layers of nickel meshes and rectangular micropores that could be transiently 
magnetized by placing permanent magnets in the 3D-printed frame. The large mesh surface 
area enabled cell enrichment by capturing magnetically tagged target cells passing through 
the large cross-section of the tip and allowed for releasing cells by manual pipetting and 
release of the magnetic field. The authors demonstrated performance of the MACS Tip by 
sorting bacterial cells from whole blood and their identification via PCR. Owing to this 
method’s ability for cell isolation, washing, and release, downstream analysis could be 
realized.
Xu et al.92 utilized a combination of microchip-based CTC capture with multifunctional 
magnetic assays. It was comprised of anti-EpCAM antibodies conjugated to a 
Fe3O4@C6/Ce6@ silane assembly and an inverted microchannel with a silicon nanowire 
capture surface. The assay provided fluorescence readout of enriched CTCs following 
capture, and a high purity of CTCs generated by the CTCs being pulled up to the capture 
surface, while other cells and metabolites were pulled down by gravitational forces. The 
authors also integrated a CTC photodynamic therapy in vitro that was realized with confocal 
laser scanning microscopy. The results indicated attributes of the magnetic composite labels, 
which greatly improved the capture purity of the CTCs to 90% and provided capture 
efficiency of 82% with 2 mL/h flow rates.
Zhao et al.93 developed a CTC enrichment method based on cell magnetization in a 
ferrofluid. The so-called integrated ferrohydrodynamic cell separation (iFCS) merged two 
phenomena: (i) “diamagnetophoresis” and (ii) magnetophoresis” of cells in a biocompatible 
ferrofluid. Enrichment of CTCs was accomplished via antigen-independent mode and the 
cell size variation-inclusive method. The assay allowed for depletion of WBCs while 
enriching viable CTCs for clinical applications.
Fluorescence-Activated Cell Sorting.
Flow cytometry is widely used as a method for sorting cells at rates of 102–105 events s−1. 
Recently, reported microfluidic designs of fluorescence-activated cell sorters (FACS) 
demonstrated high levels of integration to address challenges of conventional flow 
cytometers. Microfluidic chips can integrate components such as microchannels, optical 
components, and actuators to generate miniaturized systems. Cells can also be encapsulated 
in droplets and electrostatically deflected into collection containers depending on 
fluorescence in FACS.
De Wijs et al.94 reported a microvapor bubble jet flow for high-rate fluorescence-activated 
cell sorting (Figure 5A). The authors used a resistive metal heater to generate microvapor 
bubbles of reproducible volume, quantity, and lifetime. The authors demonstrated sorting of 
fluorescent beads at high rates and the enrichment of rare cells. Compared with other 
microfluidic sorting mechanisms, jet flow sorting was not dependent on any physical cell 
characteristic. The jet flow sorter was reported to be simple to fabricate and operate. The 
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system did not contain mechanical parts and could be operated with a low power laser for 
bubble creation.
A spark-generated microbubble cell sorter for microfluidic flow cytometry was reported by 
Zhao et al.95 (Figure 5B). The advantage of this setup was realized based on a jet flow 
induced by a spark-generated cavitation microbubble that can be produced by a pair of 
electrodes. The sorter was integrated into a microfluidic chip with three-dimensional 
hydrodynamic focusing and a binary optical element for laser illumination. The authors 
demonstrated sorting with a switching time of 250 μs for a sample flow velocity of 5 m/s 
and continuous operation at 200 Hz to deliver continuous sorting with good cell viability.
Image Guided Cell Sorters.
The integration of fluorescence microscopy and flow cytometry into a single platform 
provides benefits of high cell processing and analysis rates and multiparameter 
identification. Research on the development of image guided sorters and analyzers may 
provide tools for fast identification and enumeration of cells. A conventional flow cytometer 
will evaluate the fluorescence intensity of the objects of interest while the microscopic 
assessment will provide the opportunity to analyze cells based on their morphology: cell or 
nucleus size and shape, circularity, fluorescence pattern of stains, and volume ratio of the 
nucleus to cytoplasm.
Technology in cell sorting was shown based on nuclear localization of glucocorticoid 
receptors, particle binding to the cell membrane, and induced DNA damage. Okumus et al.96 
reported a MACS platform that overcame challenges of visualization of cells in suspension 
by temporarily immobilizing cells within a microfluidic chip. This enabled high-throughput 
and automated single-cell microscopy for a wide range of cell types and sizes. MACS 
facilitated the visualization of individual cytoplasmic fluorescent proteins in E. coli, 
allowing low-abundance proteins to be counted using total internal reflection fluorescence 
microscopy. MACS also was used to impart mechanical pressure on cells for assessing the 
structural integrity of individual cells.
Isozaki et al.97 designed an intelligent image-activated cell sorter (iIACS) that delivered real-
time image-based sorting of single cells with high throughput. iIACS was capable of 
analyzing fluorescence intensity profiles of cells and multidimensional images for sorting 
cells with unique morphological traits. In fact, orthogonality (i.e., the number of pixels 
multiplied by the number of colors) was ~1 000 times greater than that by FACS (i.e., ~20 
colors without spatial resolution). The method was based on integration of high-throughput 
cell microscopy, cell focusing and sorting, and deep learning on a hybrid software-hardware 
data management infrastructure that enabled data acquisition, data processing, intelligent 
decision making, and actuation.
Nagata et al.98 designed a diffuser-type microfluidic sperm sorter (DMSS) device (Figure 
5C). Manipulation of fluid flow in microchannels allowed for the isolation of undamaged, 
motile, mature, and physiologically functional sperm with high DNA integrity. The 
geometry of the microchannels consisted of three filtering zones: the crescent-shaped 
diffuser, multichannels, and a junction channel with precisely controlled fluid velocities that 
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were relevant in inducing sperm displacements and orientation. The sperm DNA 
fragmentation was evaluated before and after sorting of the sperm cells. The mean frequency 
of spermatozoa with DNA fragmentation was 0.4% and 7.1% for DMSS-sorted and unsorted 
sperm, respectively, indicating that sperm selection by DMSS allows for effective recovery 
of not only viable and motile but also functional sperm cells with very high DNA integrity.
Spatiotemporal Image Correlation Analysis for 3D Flow Field Mapping in Microfluidic 
Devices to measure how flows evolve from 3D structures was established by Ceffa et al.99 
The authors demonstrated the ability of mapping 3D flows in complex microchannel 
networks by combining wide field illumination to image correlation approaches. The work 
derived the spatiotemporal image correlation analysis of single-plane illumination 
microscopy images and developed a fitting method to measure in-plane and out-of-plane 
velocities.
Edwards et al.101 developed a methodology that integrated organ-on-chip-like microfluidic 
and photoconvertible protein technologies to investigate cancer cell dissemination processes. 
The authors evaluated natively expressed selectin ligands correlation with colon cancer cell 
rolling frequencies and velocities. They could assign a single-cell velocity as a useful cell 
property for further analysis of cell molecular profiles and adhesive phenotypes.
Gu et al.102 demonstrated an image-guided cell sorting and classification system possessing 
a throughput comparable to conventional flow cytometry with the high information content 
of microscopy. The utility of this technology in cell sorting was shown based on nuclear 
localization of glucocorticoid receptors, particle binding to the cell membrane, and induced 
DNA damage.
Optofluidic Cell Sorting.
An image-activated cell sorter that integrated cell microscopy, cell focusing, and cell sorting 
on a hybrid software-hardware data-management infrastructure enabled real-time automated 
operation for data acquisition, processing, identification, and actuation. Nitta et al.103 
presented this so-called optical-microfluidic-electrical-computational-mechanical system 
demonstrating high flexibility and scalability, automated operation for data acquisition and 
processing, and importantly decision-making and actuation all within 32 ms even for deep-
learning algorithms.
Yu et al.29 reported an automated system for the identification of cells with morphological 
features using optical imaging and a designed classification algorithm. A microfluidic device 
provided a customizable platform for cell sorting based on image processing. On-chip valves 
and pumps allowed for cell isolation and shuttling to an observation window for 
confirmatory analysis. The system was designed to operate in two modes: the forward 
sorting mode, where the sample passed through a flow-focusing unit and, with the aid of 
sheath flow, cells could pass aligned through the cell identification region. If a cell was 
classified, the valves in the two sorting channels direct cells to a collection or waste 
reservoir. In the second mode, called a reverse identification mode, the cells stored in the 
chamber were pushed back toward a reverse waste reservoir and passed through the 
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identification area that looked for the presence of fluorescence markers. The automated 
device delivered low-cost image processing and cell sorting.
Work by Hamza et al.104 addressed challenges related to low blood volume samples 
available for CTC testing in longitudinal studies in animal models. They developed an 
optofluidic system (Figure 6D) capable of identification of fluorescent CTCs and their 
direction to a collection well for analysis. Cancer cells in this mouse model produced 
fluorescence, including CTCs. The analysis system included a microfluidic CTC sorter chip, 
a fluorescence detector, and computer-controlled pneumatics. This CTC chip was connected 
to the mouse via left carotid artery and the output blood from the chip was infused back into 
the mouse through the right jugular vein at a rate of 30 μL/min. Two closely spaced laser 
beamlines illuminated the main flow channel of the chip to monitor CTC abundance and 
perform sorting. Each fluorescent cell that passed through the device emitted two pulses of 
light, which were detected by a PMT. The controller operated pneumatic valves to redirect a 
small blood volume with the CTCs toward a collection tube. CTCs in blood from the 
collection tube were further enriched by a secondary single-CTC sorting chip and further 
analyzed. The authors used scRNA-Seq to show that continuous CTC capture from the same 
murine animal eliminated bias driven by interanimal heterogeneity that occurred when CTCs 
were collected across different mice.
Hu et al.105 used optofluidics for the isolation of CTCs based on their interactions with 
RBCs via folate receptors. Complexes of cancer cells with RBCs were sorted under laser 
illumination in an optofluidic system with 92% purity and >90% recovery. The combination 
of RBC binding and an optofluidic system provided a potential tool for early detection of 
cancer.
Another application of optofluidics was demonstrated by Landry et al.23 who developed a 
method for single-cell genome amplification from sorted via an optical trap bacterioplankton 
cells. The device retrieved diverse single-cell bacterioplankton genomes and offered utility 
in microbiology applications that required working with small sample volumes.
Lee et al.16 described the optimization of a Raman-activated cell-sorting system. This 
optofluidic platform performed automated sorting of isotopically labeled microbial cells and 
combined microfluidics, optical tweezers, and Raman spectroscopy to achieve sorting of live 
cells as verified by cell culture. The sample enrichment and preconcentration was needed for 
single-bacterial cell genomic analysis. Design testing with bacterial cells showed 98% 
sorting efficiency with a throughput of 500 cells/h. Liu et al.106 developed an optofluidic 
platform for bacterial cell sorting. Fiber tweezers were integrated into a microfluidic channel 
to build a chip that trapped bacterial cells based on size and shape. E. coli trapping from 
blood was empirically evaluated and compared with simulations for the trapping of different 
shapes of cells, including bacterial and mammalian cells. The advantages of the system 
included low optical power and compact construction, all important for potential field 
testing.
Tkachenko et al.107 reported an optical device for trapping of micrometer sized objects using 
planar silicon metalenses illuminated with a collimated laser beam. The metalenses in the 
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system consisted of high-contrast gratings with a varying period and duty cycle and 
parabolic reflectors. Both, two- and three-dimensional trapping in water was demonstrated. 
Lithographically made metastructures for sorting with optical forces replaced the need for 
bulky optical elements. Design of the focusing optics in a planar format was attractive and 
conducive to the integration of microscale devices.
Droplet Cell Sorting.
Due to the similarities in volume between droplets and cells, a droplet represents a self-
contained sample vessel or microreactor for a single cell, allowing for parallel studies and 
high-throughput analysis.108 Formation of droplets in microfluidics provides the advantage 
of creating a monodisperse population of droplets. Sorting of droplets requires the ability to 
discriminate their properties when biologicals are contained within them. To achieve this, 
different phenomena have been used to classify droplets based on their content. 
Discrimination can be accomplished based on droplet size, electrical, magnetic, or optical 
properties.109
Jyoti Dipanka Shaikeea et al.110 utilized a process of a naturally evaporating colloidal sessile 
droplet interacting with a porous silica gel bead to mimic a so-called mechanical crane 
assembly. This particular mechanism involved self-assembly along a droplet-bead interface 
and bonding. The evaporating droplets automatically lift the bead. These observations across 
multiple spatiotemporal scales provided insights into the design of droplet engineering.
Turk-MacLeod et al.111 proposed to sort objects in an ensemble rather than as discrete 
objects. A set of so-called registers were sorted and then sorted again into a second 
symmetric set of registers without loss. The process was repeated resulting in high sorting 
purity. The system was modeled and tested on objects spanning several orders of scale, from 
macroscopic beads to micrometer sized droplets.
Yu et al.112 reported an on-chip encapsulation and analysis of protoplasts at processing rates 
of >100 000 cells/h. The work demonstrated the ability to dielectrophoretically sort droplets 
containing fluorescing protoplasts from nonfluorescent control cells. A microfluidic system 
was used for quantification of the stochastic properties of a heat-induced promoter in a 
population of transgenic protoplasts and to demonstrate the ability to evaluate gene 
expression modulation in response to environmental conditions.
Pan et al.113 presented a droplet microfluidic for label-free and passive selection of live 
cells. The method, named sorting by interfacial tension (SIFT), discussed an interesting new 
strategy to sort viable cells. The selection and sorting of droplets was based on metabolic 
activity of individual cells and interfacial tension of droplets. Release of lactate by viable 
cells resulted in a pH decrease, which changed the interfacial tension of droplets when a 
particular surfactant was used for droplet preparation.
Fluorescence-based droplet sorting was employed by Shembekar et al.114 The authors 
presented a high-throughput droplet microfluidics approach employing dual-color 
normalized fluorescence readout to detect antibody binding. The assay allowed collection of 
quantitative data related to cell antigen recognition using minute amounts of antibody. 
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Specific binders of target cells coencapsulated into droplets enriched 220-fold following 
sorting of 80 000 clones. This droplet-based assay would allow for therapeutic antibody 
discovery using primary human plasma cells.
Qin et al.122 discussed work on a fluorescence-activated single-droplet dispenser (FASD), 
that used cytometric detection and electrohydrodynamic actuation-based single-droplet 
manipulation. FASD allowed for droplet isolation and dispensing with high efficiency and 
accuracy. Droplets could be collected into conventional multiwell plates or secondary large-
scale screening systems.
Buryk-Iggers et al.123 demonstrated a diamagnetic droplet microfluidic method in which 
cell-encapsulating droplets were precisely controlled based on magnetophoresis, a 
phenomenon where particles migrate in a magnetic field. The droplet phase was comprised 
of cells suspended in culture medium, and the magnetic content was contained in the 
continuous phase. Encapsulated cells produce larger droplets when compared to empty ones. 
By the application of a magnetic field, diamagnetic size-based sorting of empty droplets 
from cell-encapsulated droplets was achieved. The same research group explored a similar 
concept115 and demonstrated the integration of ferrofluids in a polymeric aqueous two-phase 
system to achieve diamagnetically responsive water-in-water droplets (Figure 6A).
Li et al.116 presented work on the acoustophoretic system for fluorescence-activated sorting 
at the single-droplet level (Figure 6B). The fluorescence-activated droplet sorting technique 
acted along with focused traveling surface acoustic beam of ~50 μm with a resonance 
frequency of 98 MHz. When an individual droplet containing fluorescently labeled cells 
passed through the laser spot (i.e., fluorescence interrogation region), the fluorescent label 
was excited and the emitted light transmitted to a PMT that converted the received light 
intensity into an electrical signal. Each high-level electrical pulse signal from the PMT 
triggered a radio frequency (rf) generator to produce a pulsed ac signal. The ac signal after 
power amplification was applied to a FIDTs to generate a focused traveling surface acoustic 
wave (FTSAW) beam resulting from the piezoelectric effect. When the FTSAW traveled 
along the surface of the FIDT device and encountered a micropillar, it radiated into the 
micropillar that acted as a waveguide to locally transmit the FTSAW into the sorting region. 
A frequency of ~1 kHz delivered 90% purity of sorted events. The detachable acoustic 
droplet sorting system allowed the reusability of the costly FIDT device and avoided sample 
cross-contamination by adopting a single-use microfluidic channel device.
Kim et al.117 also described a droplet-based system for single-cell reverse transcription 
polymerase chain reaction (RT-PCR) (Figure 6C). The device combined biological cells with 
lysing buffer using droplet generation and mixing of these droplets in a microfluidic T-
junction with larger volume droplets containing enzymes and reagents for RT-PCR.
Schaerli et al.26 demonstrated a microfluidic method for high-throughput screening of 
bacterial cells in gel-based emulsion beads. Beads were incubated allowing for fluorescently 
tagged cells to grow into monoclonal colonies inside the beads. By identification based on 
fluorescence, very specific colonies were selected by FACS. Following FACS, the bacteria 
were recovered from the gel beads and ready for further analysis.
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Zhu et al.124 reported quantitative proteomic analysis of single mammalian cells utilizing a 
nanodroplet sample processing chip along with ultrasensitive nanoLC-MS. The system was 
demonstrated with model cell lines with identification of even a single cell due to high-level 
proteome coverage.
Utharala et al.125 described a microfluidic platform for partitioning and sorting particles 
including molecules, cells, and embryos. The system was attached to a fluorescence 
microscope. The platform contained valves used for opening and closing microfluidic 
channels to enable sorting rates >2 Hz. The microfluidic also performed 8-way sorting, 
simplifying the simultaneous enrichment of objects based on their particular characteristics 
or phenotype.
Chung et al.118 reported a microfluidic system that coupled continuous-flow droplet-
generation and sorting with droplet merging allowing for addition of reactants or biologicals 
to the droplets (Figure 6D). The platform included multiple steps for manipulation of 
droplets. The process began with the generation of 125 μm large droplets containing, for 
example, enzymes, primers, or the appropriate buffer. In order to add reactants or cells to 
this droplet, smaller droplets were generated (~60 μm) containing both cells and lysing 
buffer. Cells and lysis buffer do not mix before coencapsulation in a droplet, so lysis 
occurred only in the droplet. A fluorescence-activated droplet sorter selected droplets that 
contained cellular material based on fluorescence coming from the nuclear DNA. Merging 
of small and large paired droplets was executed by applying high voltage electric fields that 
induced dielectric forces. The system was successfully tested for single-cell reverse 
transcription loop-mediated-isothermal amplification to quantify mRNA expression levels.
Segaliny et al.119 used droplet microfluidics for screening and real-time monitoring of the 
activation of T cells expressing an engineered T cell receptor (TCR) following the 
recognition of tumor cells (Figure 6E). The idea behind this work stemmed from a need of 
identifying candidate T cell therapeutics for cancer treatments and the requisite for 
understanding their TCR sequence. The authors demonstrated visualization of the dynamics 
of TCR T cell interactions with target cells, measured the activation kinetics, sorted TCR T 
clones using laser-based cavitation, and performed downstream molecular analysis using 
single cell RT-PCR and sequencing.
Ahmadi et al.120 presented an integrated digital-droplet microfluidic that combined the use 
of single-plate digital microfluidic chip and droplet-in-channel microfluidics (Figure 6F). 
The system featured on-demand mixing of droplets and facilitated creation of different 
concentrations with multiple additions using an electric potential without the need for 
optimizing flow rates. Overall, the following stages were included within the system: droplet 
generation by a flow-focusing or T-junction configuration, droplet mixing, incubation, 
detection, and sorting. The authors also incorporated traps allowing for droplets to be 
incubated for extended periods of time. Application of this microfluidic device to the study 
of the effect of an ionic liquid on yeast cells was demonstrated.
Li et al.121 designed an array-based emulsification method for the generation of 
monodisperse agarose-in-oil droplets for application in single copy DNA amplification in a 
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microwell array (Figure 6G). Agarose monodispersed and size-tunable droplets were formed 
when hot oil was introduced into an agarose solution contained in wells. The droplet size 
formed depended on the array unit depth and width. More than 100 000 uniform droplets 
were generated in less than 1 min using a preformed agarose well array. A single-copy of 
DNA was efficiently amplified in picoliter droplets, enabling accurate absolute quantitation 
of DNA molecules.
Hybrid-Based Methods Employing Cell Separation and Sorting.
Cells of various types and function may often differ in size, stiffness, and/or deformation 
response. A number of physiological states can alter these cellular characteristics, and 
therefore sorting/separation technologies aimed at exploiting these traits can be useful in a 
variety of settings. The aforementioned cellular characteristics can be used to separate 
and/or sort cells either in discrete devices or in combination on a single device.
Size and Elasticity Cell Separations and Sorting.
The effects of circular, irregular, and rectangular microchannel cross sections on the forces 
that act upon normal and stiffened RBCs were studied by Chen et al.,126 who performed 
flow simulations to analyze distribution effects on cell movement in geometrically different 
microchannels. Additionally, migration velocities of RBCs in viscoelastic solutions were 
deduced. A microfluidic device developed by Yuan et al.127 coupled the effects of fluid 
elasticity, inertial, and Dean-flow forces to accelerate particle focusing in a serpentine 
microchannel by adding elasticity-altering polymers to the sample.
Du et al.128 demonstrated that applied stress in the form of atomic force microscopy (AFM) 
can be used to precisely identify mechanical distinctions in different stem cell populations in 
regards to deformability and rupture response; AFM-induced stress could potentially be 
utilized as a label-free marker in microfluidic systems. A microfluidic device utilized 
periodic diagonal ridges to sort drug-resistant and leukemia cells by differences in stiffness 
after treatment with chemotherapy in a label-free manner, achieving up to 93% purity. 
Sorted cells were tested for their gene expression and AFM was used to validate that sorting 
was accomplished via stiffness. Islam et al.129 used a ridged-microfluidic device to sort 
drug-resistant and sensitive leukemia cells by differences in stiffness after chemotherapy. 
Their experimental results were validated by AFM analysis.
Bongiorno et al.130 utilized AFM to evaluate biomechanical properties of cells. Based on 
their findings, the authors employed a microfluidic device for the enrichment of pluripotent 
cells based on their characteristic stiffness. The device was employed to sort a differentially 
labeled mixture of pluripotent and differentiating cells, resulting in pluripotent cell 
enrichment. These properties were verified via phenotyping, postsorting characterization of 
cell mechanics, morphology, and gene expression. Findings from the aforementioned 
publication suggested that cell mechanical properties may serve as a metric for a label-free 
isolation of stem cells to facilitate study of pluripotency and advance the field of tissue 
engineering and regenerative medicine in the future.
Girardo et al.131 demonstrated high-throughput production of elastic microgel beads that 
mimic cell elastic properties. Beads were employed as calibration standards for different 
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mechanical techniques for studying cell biomechanics. The authors presented methods for 
functionalization of beads to further applications in cells and organoids for tissue mechanical 
characterization. These beads could serve as useful models in cell cultures, for example, to 
study the effect of stress acting on nuclei during cell division.
A wedge-shaped microfluidic device made from two glass slides was able to separate spiked 
CTCs in blood with ~90% efficiency. The device was composed of a wedge-shaped 
microchamber, two inlets, a linear reservoir, and one outlet. The microchamber was the 
principal component of the chip, and Yang et al.132 evaluated the effect of size-cutoffs for 
CTCs on capture efficiencies by altering the chamber outlet height. Due to biophysical 
differences of size, stiffness, and deformability between CTCs and RBCs, CTCs were 
separated from RBCs efficiently in microchambers when the cutoff height was larger than 
that of RBCs but smaller than most of the CTCs. RBCs freely flowed through the chamber 
whereas CTCs were physically trapped (i.e., separated). The unique wedge shape allowed 
for a size-cutoff of 5 μm to entrap CTCs from blood. The device was also able to incorporate 
high-resolution fluorescence imaging (Figure 7A).
A multilayered microfluidic device that achieved filtration via a nylon mesh was recently 
developed to achieve separation of tissue fragments, cell aggregates, and single cells from 
digested murine kidney and mammary tumor tissue samples. Two microporous membranes 
worked together to accomplish filtration, with the first membrane poised to restrict large 
tissue fragments and the second membrane to restrict smaller aggregates from reaching the 
outlet (Figure 7B).133 The device was designed to operate in either a traditional direct 
filtration mode, or a tangential filtration mode that utilized a cross-flow to prevent 
membrane clogging. Qiu et al. presented the ability to separate up to 85% of cell aggregates 
and clusters in just 15 min, yielding comparable results to a full 60 min traditional tissue 
digestion.
Ren et al.134 fabricated microgel beads to be used as an elasticity comparison for the 
classification of cancer cells from normal cells. They demonstrated a microfluidic that 
exploited confining capture chambers capable of achieving classification rates >75% when 
exposed to whole blood containing breast cancer cell lines. Microgel beads were mixed with 
cell samples, and penetration differences seen by captured cells in the confining chambers 
afforded differentiation between beads and normal or cancerous cells (Figure 7C).
A lattice-patterned microfluidic device accomplished size-based enrichment of 3 and 10 μm 
particles using dual-depth asymmetrical microchannel networks. The device utilized three-
dimensional (3D) hydrodynamic flows to accomplish separation of various sized particles. 
The dual-depth lattices enabled Yanai et al.135 to create an anisotropic flow distribution at 
microchannel crossing points. Main channels were slanted, whereas the perpendicular 
separation channels were shallower. Observations of these channels revealed complex 3D 
flows that dominated size-dependent differences in particle behaviors (Figure 7D).
A pump-free single layer microarray fabricated in PDMS was developed for the trapping of 
single cells using cell membrane permeability as a mode for cell separation (Figure 7E). The 
device featured an array of ~77 symmetrical butterfly shaped traps functioning as a trapping-
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DLD hybrid, which deflected particles larger than the critical size, while also enabled 
trapping of particles with a diameter smaller than Dc but larger than the aperture width. 
Microspheres (18.8 μm diameter) were used as a model and were trapped via deterministic 
lateral displacement with 86.8% occupancy. Weng et al.136 utilized the device to determine 
the membrane permeability of rat hepatocytes and CTCs.
Hydrodynamic filtration (HDF) was utilized to achieve size-based sorting of particles and 
blood cells at a particle sorting throughput of 15 mL/min using a recently developed 
stackable microfluidic device (Figure 7F). HDF utilized a continuous laminar fluid flow that 
was introduced in the left-to-right direction in a straight channel with perpendicular 
branched cross sections. When the relative flow rates to the side channels were low with 
respect to the main channel, only a small portion of liquid was directed into the side 
channels, making it impossible for particles to enter the branches. By increasing flow rates 
into the side channels, aligned particles could be collected according to size. By taking 
advantage of this phenomenon, the device was able to achieve ~4000-fold enrichment of 
WBCs from a diluted blood sample.137
Mehendale et al.138 combined the advantages of dead-end and cross-flow filters in a 
separation device called the Radial Pillar Device (RAPID), which was able to sort large and 
small rare particles from a mixed population without clogging at a flow rate of 3 mL/min. 
From a mixture containing 2, 7, and 10 μm particles, the device sorted 2 and 10 μm particles 
with 90% purity and recovery.
Kamyabi et al.139 were able to isolate CTC clusters from 1 mL of whole blood in under an 
hour by using a microfluidic device equipped with 10 000 trap chambers. Cluster separation 
was accomplished based on size and dynamic force balanced against a flow-bifurcating-
pillar within the trap chambers. Capture and release efficiencies of 66–87% and 76–90%, 
respectively, were observed using this device.
The Parsortix cell separation system was developed to capture and separate rare cells from 
blood based on cell size and deformability. Harvested cells from the system were 
successfully assessed via cytological methods including fluorescence in situ hybridization 
(FISH). The system demonstrated 81% capture and 74% harvest rate.140
Wang et al.141 developed a microchip for sized-based single-cell isolation. The chip 
contained several isolation units consisting of trap, bypass, and release channels. Larger 
tumor cells were preferentially confined in the trapping channel due to low flow resistance. 
Once a cell was confined, the flow resistance increased significantly and cells flowed 
through the bypass channel warranting single-cell entrapment. Bypass channels were 
designed with a width to allow passage of a single row of cells. Captured cells were released 
with a microvalving system redirecting flow, affording both, the recovery and purity of CTC 
models of ~93%.
Dielectrophoretic Cell Separations and Sorting.
Dielectrophoresis (DEP) utilizes nonuniform inductions and attractions of displaced charges 
within particles or cells to affect sorting or separation processes.142 Externally applied 
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alternating (ac) or direct current (dc) can enable the separation or sorting of cells due to 
differences in cell polarizability. DEP is able to manipulate and separate cells without the 
need for biochemical labels or other tags and without contact to any surface.143 While most 
of these devices trap cells near a particular electrode due to the cell’s unique electrical 
properties, in some cases DEP devices can be operated in a cell sorting mode of operation as 
well.
Puri et al.144 performed a comparative analysis of yeast cell sorting efficiency using gold 
and carbon electrode DEP devices. In this work, the authors emphasized that carbon 
electrodes could function as a durable low-cost alternative to noble metal electrodes.
Adams et al.145 published work demonstrating three different DEP-based devices for the 
separation and sorting of neural stem and progenitor cells. These devices included a DEP 
microwell, an automated DEP with 6 000 cells/h throughput and a large capacity electrode 
array (LCEA) capable of 150 000 cells/h throughput. The DEP microwell device consisted 
of a 3 × 5 microwell array fabricated in PDMS with gold electrodes at the bottom of each 
well. Specific cells were separated along the electrode edges and cells that did not 
experience positive DEP (pDEP) remained in suspension above the electrodes. A wash 
buffer removed nontrapped cells while the electric field was still on, and this process was 
repeated until a sufficient number of cells were collected. The automated DEP device had 
microfluidic channels with three castellated electrode regions for cell trapping and an 
additional array for cell screening. One main microfluidic channel branched off to five 
different channels for collection. Fluid flow was controlled by a valving system. Once cells 
were trapped, fluid flow was stopped and the applied electric field frequency reduced, which 
released a subset of cells. The released cells were directed to collection outlets by opening 
valves while the reduced frequency was maintained. The LCEA included planar 
interdigitated electrodes with two inlets and one outlet. Once cells reached the electrode 
region, the electric field was turned on and viable cells experienced pDEP and were retained. 
Cells were then released by lowering the frequency incrementally and collected at an outlet 
port.
Schucat et al.146 designed an electrode array in a microfluidic device to act as an automated 
platform for sperm cell separation. A quadrupolar electrode array was fabricated onto an 
indium tin oxide (ITO)-coated glass slide using photolithography and wet-etching and a 
PDMS microchannel was utilized to examine the effects of different DEP forces on sperm 
cells. The study observed that the head and tail of the spermatozoa exhibited independent 
DEP behavior, either pDEP or negative DEP (nDEP) at a particular frequency. The tail of the 
sperm cells switched from a nDEP response to a pDEP response at low frequency. There 
was a range of frequencies where the sperm head underwent nDEP while the tail underwent 
pDEP providing proof-of-concept that DEP has the potential to automate and improve 
semen sample separation without damaging the cells. For a prototypical chip, researchers 
fabricated a pair of curved electrodes to which the sperm tail was attracted and the head 
repelled, resulting in perpendicular sperm cell alignment. Depending on electrode design, 
the researchers concluded that pDEP can be safely used as a mechanism to separate sperm 
cells from debris.
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Coupling DEP and Raman spectroscopy, Hanson et al.21 were able to successfully isolate a 
mixed sample of bacteria and 3 μm polystyrene particles from each other. The device 
consisted of two pillar arrays for debris removal and bacterial trapping for label-free Raman 
spectral analysis, enabling 100% classification accuracy among closely related bacteria.
By combining DEP and hydrodynamic drag forces, Xing et al.147 fabricated a microfluidic 
device for continuous-flow cell sorting (Figure 8A,B). Silicon microelectrodes acted as 
physical tracks that rail cells away from incoming streams of fluid. For cell sorting, a stream 
of cells was introduced and flanked by a sheath flow into the flow chamber toward the side 
that was in support of the cell railing. Uninterrupted flow was ensured by passages beneath 
the railing tracks. Nontargeted cells experienced nDEP and reached the primary outlet, 
whereas target cells experienced pDEP and were railed along the tracks. The device was able 
to sort a binary mixture of different cancer cell lines with collection efficiencies >85% at a 
sample flow rate of 0.5 mL/h. Another microfluidic device that coupled both DEP and 
hydrodynamic forces was able to isolate lung cancer cells from RBCs at a sorting efficiency 
of 91.7% for RBCs and 100% for cancer cells. DEP was accomplished by 3D sidewall 
electrodes, and the hydrodynamic unit was composed of contraction and expansion 
microchannels to increase the electric field gradient, hence, enhancing DEP forces imposed 
on the cells. These enhanced forces acted as an additional shear gradient lift force to induce 
secondary flow.149
A microfluidic device by Wu et al.148 utilized actuation and bipolar electrodes in DEP to 
accomplish multiple functions: cell sorting, single-cell trapping, and cell manipulation 
(Figure 8C). Actuation electrodes were patterned on the bottom of the device and deflected 
cells into a buffer stream due to strong nDEP forces. Bipolar electrodes consisted of 
electronic conductors in contact with an ionically conductive medium in which a linear 
potential gradient was generated between the ionic solution and the electrodes by applying a 
voltage between the driving electrodes. In this device, each bipolar electrode floated to an 
equilibrium potential controlled by the solution potential gradient, which allowed for single 
cell trapping, rotation, and propulsion. Single cells were trapped and manipulated by altering 
the distribution of an ac electric field via these bipolar electrodes. Yeast cells were sorted 
from polystyrene microbeads with >90% efficiency, and single yeast cells could be trapped 
with 72% efficiency. Additionally, yeast cells were oriented and steered around the device at 
a speed of 94.2 μm/min by using DEP at the bipolar electrodes.148
Single-particle manipulation by optically induced dielectrophoresis (ODEP) was first 
described by Chiou et al.150 Indium tin oxide glass and a layered photoconductive surface 
were necessary to achieve ODEP. When projected light hits the photoconductive layer, 
virtual electrodes were turned on to create nonuniform electric fields, which allowed cell 
manipulation. This photoconductive layer could be applied in specific patterns and cells 
could be either attracted or repelled by an illuminated area depending on the ac frequency 
generated and the dielectric properties of the cell. ODEP has seen usage in the realm of cell 
sorting and separation. Chiu et al.151 took advantage of this in a study for the isolation of 
CTC clusters from blood, affording cell purity and recovery of 91.5 and 70.5%, respectively. 
The device used a dynamic square light image array for continuous cell isolation from 
background WBCs based on significant size differences; the clusters were diverted to a side 
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microchannel for further purification. Additionally, ODEP has been used with fluorescence 
microscopy in a microfluidic device to achieve isolation of live CD45(−)/EpCAM(−) cells 
from blood samples with purity ~100%.152
Thomas et al.153 described a system in which a “virtual channel” generated by negative 
dielectrophoresis is utilized for cell sorting. This virtual channel runs along the center of the 
microfluidic channel and automatically directed cells along a specific path by switching the 
polarity of the electrodes; the system interpreted video data and sorted it based on color, 
intensity, size, and shape. Researchers were able to sort osteosarcoma and human bone 
marrow cells with 74% recovery at a flow rate of 60 nL/min.
Impedance Cytometers: Label-Free Counting of Enriched Cells.
Impedance measurements of biological cells is a label-free, noninvasive, and quantitative 
analytical method. Impedance sensing is based on measuring the impedance from a 
frequency-dependent voltage signal (i.e., excitation signal) applied to the target. Impedance 
measurements provide the opportunity for high-throughput analysis of cells and particles, 
which is convenient when a large number of particles or cells need to be characterized and 
counted. Solsona et al.154 addressed challenges related to the detection of the exact position 
of cells or particles as they enter the sensing zone between the electrodes when impedance 
data are collected. Using platinum electrodes fabricated as an array with a gradually 
increasing surface area, the authors demonstrated that an electric field gradient in a parallel 
two electrode array allowed for tracking of particle position in one axis. By using low 
frequency measurements, it was possible to detect the exact position of the particles. At 
higher frequencies, where the impedance of the medium dominates and the current density is 
homogeneous throughout the entire electrochemical cell, the conductivity of particles or 
cells can be measured. Studies used a finite element model to define the frequency range at 
which both the position and conductivity of the particles or cells can be detected and 
measured. The model was validated with microparticles using a microfluidic chip with 
linearly increasing electrodeposited areas perpendicular to the flow direction.
Petchakup et al.155 reported on leukocytes sorted from blood using a Dean flow fractionation 
device and follow-up impedance profiling of sorted cells (Figure 9A,B). The detector 
consisted of a three-electrode setup; the middle electrode was supplied with potential at two 
different frequencies and the differential current response from cells was recorded from the 
side electrodes and sent to a lock-in amplifier to extract a magnitude and phase of the signal 
of interest. In this application, a microfluidic impedance flow cytometer was used for testing 
and characterizing neutrophils and monocytes obtained from patients with type 2 diabetes. 
Here, leukocyte dielectric properties were associated with cardiovascular risk factors. 
Additionally, tested cells demonstrated pro-inflammatory phenotypes, which would imply 
that leukocyte impedance signatures could be used as a biomarker of inflammation. The 
method was also able to monitor monocyte differentiation and provide biophysical 
characterization of monocyte subsets.
Yang et al.,156 similar to the work of Solsona et al.,154 demonstrated an impedance sensor 
consisting of a three electrode detector with an N-shaped design. The microfluidic 
impedance flow cytometer was designed in that way to provide information on the lateral 
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position of measured cells and particles. A differential current collected from the N-shaped 
electrodes encoded the trajectory of flowing single particles (Figure 9C).
Research results presented by Honrado et al.33 evaluated changes in biophysical properties 
of RBCs during the malaria infection cycle using an impedance sensor (Figure 9D). 
Microfluidic impedance cytometry measured the dielectric properties of Plasmodium 
falciparum-infected RBCs, and the results demonstrated that the membrane capacitance and 
cytoplasmic conductivity of infected RBCs increased during the time course of the infection, 
possibly correlating with the increasing volume occupied by the parasite. The authors 
suggested that their findings could be used for the development of DEP-based sorting of 
RBCs as a standard parasite detection protocol during post ring-stage of the infection cycle 
with increasing sensitivity over current diagnostic methods. The cell or particle lateral 
position was derived from the measured electrical signal and distance relationship between 
the positions of particles, electrodes, and microchannels. The results demonstrated that the 
device could measure the lateral position of single particles and cells while simultaneously 
characterizing their size.
Integrated Systems for Cell Analysis.
Li et al.157 demonstrated and validated in clinical work an integrated system for processing 
blood samples and whole genome amplification (WGA) of gDNA isolated from CTCs 
(Figure 10A). All steps, including blood filtering, CTC enrichment, identification, isolation, 
lysis, and WGA were performed on a single device. The authors established a so-called 
“whole blood in, WGA product out” concept by incorporating multiple analysis steps for 
analysis at the single-cell level. The integrated chip incorporated novel tristate valves that 
could perform the role of a valve and an active mixer to ensure successful single cell WGA.
Zhang et al.158 reported an integrated system that used a disposable microfluidic device and 
a fluid control system for label-free automated cell separation (Figure 10B). The instrument 
consisted of the following components: a flow inlet chip for sample and sheath streams, a 
flow regulatory chip for flow rate regulation, two cell separation chips, and a flow outlet 
chip for waste and product collection. Chips were fabricated with four layers of adhesives. 
The sample and sheath fluids were infused into the flow inlet chip under pressurized gas and 
flow was regulated by another so-called regulatory chip with passive microvalves. Cell label-
free sorting was accomplished by Dean-flow fractionation (DFF). The chip design included 
spiral channels patterned in parallel, with each spiral channel maintaining two inlets and two 
outlets. In the spiral channel, sample and sheath were introduced into the outer and inner 
inlets, respectively. Model cell lines were isolated from blood with a recovery of ~85% 
within 20 min. The instrument provided rapid cell processing.
Tian et al.14 designed a microfluidic with 1.5 μm posts spaced 2 μm apart to arrest cells on a 
micropillar array (Figure 10C). The device provided means to trap a single cell and lyse it 
on-chip with the released gDNA being entangled on the micropillars owing to its length. 
Following gDNA isolation, WGA via micropillar arrays (GAMA) was performed. The 
gDNA amplified by GAMA had a higher percentage of mapped reads compared to single 
cells isolated through FACS and amplified by conventional assays. Benefits of GAMA were 
attributed to the WGA at a constant hydrodynamic flow, allowing for reagent replenishment 
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and removal of amplified products. As a result of the GAMA purification of gDNA (i.e., 
removal of lipids, proteins, RNA, and mDNA), a smaller number of artifacts were found in 
the amplification products.
An image-based cell isolation technology, DEPArray, combined microelectronics and 
microfluidics in an automated and integrated platform. The device was able to isolate highly 
pure, single, and viable cells from a heterogeneous sample. The device demonstrated 100% 
purity of isolated tumor cells from WBCs across multiple devices.159
An integrated cell sorting system, called On-chip Sort, included a disposable microfluidic 
device that afforded immunophenotype-based detection of CTCs from pretreated blood 
(removal of RBCs and WBCs). The device enabled the detection of EpCAM(−) cells when 
using an EMT marker conjugated to magnetic beads. When CTC counts for paired samples 
were compared with those isolated on an FDA approved CellSearch platform, On-chip Sort 
delivered higher clinical sensitivities. The device also enabled the molecular characterization 
of CTCs using droplet digital PCR.160
FUTURE OUTLOOK
Separating and sorting target cells from mixed populations is the first step in the cellular 
analysis pathway. As demonstrated in this review, biomolecular analysis can provide 
additional multivariate information (i.e., viability, phenotype, DNA mutational status, 
mRNA expression, etc.). For example, in the field of CTC inquiry, downstream molecular 
analysis is required to provide supporting information, as CTC enumeration alone may not 
be adequate in terms of enabling decisions on the management of various diseases.161 
Indeed, the decisions in the area of precision medicine are based on the molecular 
composition of a patient’s disease. In spite of the high analytical figures-of-merit (i.e., 
recovery and purity) associated with many of the techniques outlined in this review, biology 
may intrinsically limit the number of enriched cells available for molecular profiling as well 
as the purity of the enriched cellular fraction. For example, CTCs abundance is highly 
dependent on the stage and type of the disease and the treatment regimen of the patient.
162,163
There are a number of benchtop techniques to analyze nucleic acids or proteins contained 
within enriched cells. In the case of nucleic acids, when dealing with low copy numbers 
harvested from enriched cells, polymerase chain reaction (PCR) technologies continue to be 
the major starting point for molecular profiling because they can provide high levels of 
amplification to accommodate many downstream molecular assays, even from single cells. 
For example, droplet digital PCR (with or without reverse transcription, RNA or DNA, 
respectively) provides absolute quantification of gene expression or detection of mutations. 
Droplet digital PCR offers high sensitivity and reproducibility164 and eliminates variabilities 
with endogenous controls.165 Exome-targeted next generation sequencing (NGS) used to 
evaluate multiple exon regions for mutations166 requires an input of ~30 ng of DNA, which 
can be secured using WGA. Employing WGA can address the challenge of input mass 
requirements, however, it may create other challenges, including (i) Bias representation of 
the genome. Owing to the high GC content of the human genome and high numbers of 
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repetitive elements, the genome is biased in terms of its representation following 
amplification.167 While researchers have reported single-cell sequencing with WGA, the 
success rate of library preparation becomes a challenge and to minimize this issue, >20 cells 
are required.168 (ii) Short reads (<300 bp). Short reads can be problematic because of the 
inability to deduce the presence of large structural variations,169 the difficulty with mapping 
single-nucleotide polymorphisms (SNPs) in long repetitive regions of the genome,170 and 
the inability to do haplotyping.171 Also, genomes assembled de novo are of lower quality 
using short reads when compared to longer reads.172
The answer to many of the aforementioned challenges can be single-molecule sequencing 
(SMS).173–195 Examples of SMS platforms include Helicos,196 Genia,197,198 Pacific 
Biosystems,199,200 and Oxford Nanopore.201–205 While single molecules are sequenced, 
unfortunately, in many cases amplification is still needed to accommodate the necessary 
input mass requirements; the MinIon requires an input mass of ~1 μg of DNA.
Protein-based assays from enriched cells can include immunofluorescence with high 
sensitivity microscopy,206 Western Blotting,207 or mass spectrometry.208,209 
Immunophenotyping of even single cell using microscopy is frequently used but is labor 
intensive and requires affinity agents that target specific proteins of interest.206,210 Western 
blotting can be labor intensive, however, methods have been reported that use microfluidics 
for Western blotting.210 Finally, mass spectrometry requires input masses that are typically 
greater than 500 fM, which can create significant analytical challenges when single cells 
must be analyzed.
Therefore, new concepts for molecular profiling must evolve to accommodate the mass 
limits associated with the enrichment of rare cells from a variety of samples. For example, 
we are developing a novel single-molecule sequencing strategy that does not require PCR 
amplification. The concept is based on using a nanofluidic network to measure the 
electrophoretic mobility of single nucleotides sequentially released from intact DNA 
molecules using a surface-immobilized exonuclease.211 In the case of proteins, methods for 
single molecule identification have been devised, which use fluorescence labeling of 
cysteine and lysine residues.212 Peptides are placed on glass slides and by using total 
internal reflection microscopy, a loss of fluorescence is monitored during Edman 
degradation of peptide fragments to allow for identification. Single-molecule methods will 
not only allow for the identification of DNAs, RNAs, and proteins but can also provide 
quantitative information in a digital format, similar to what is done in the case of droplet 
digital PCR.
Coupled with new single-molecule processing strategies, the evolution of microfluidics to 
provide processing step integration will be important to realize seamless processing of rare 
cells following enrichment. For example, in this review we highlighted publications that 
have coupled cell separation/sorting technologies with downstream processing steps of the 
enriched cells. The primary advantage of building integrated systems is that they obviate the 
need for the operator to handle rare cells that can result in sample loss, contamination, or 
cell damage. In addition, the automation delivered by integrated systems will realize the use 
of these systems at the point-of-use and move forward distributive medicine in which 
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sophisticated molecular assays using liquid biopsy markers would allow for these assays to 
be carried out by novice operators and in remote settings.
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Cell affinity-isolation methods. (A) Schematic of the dual-immunopatterned (DIP) device 
composed of an anti-EpCAM antibody-immobilized layer and an anti-63B6 antibody-
immobilized layer. (a) Device concept and working mechanism and (b) structure of the 
device. Reprinted from Sens. Actuators, B, Vol. 260, Kang, Y.-T., Kim, Y. J., Bu, J., Chen, 
S., Cho, Y., Lee, Hyun M., Ryu, C. J., Lim, Y., Han, S.-W. Epithelial and mesenchymal 
circulating tumor cell isolation and discrimination using dual-immunopatterned device with 
newly developed anti-63B6 and anti-EpCAM, pp 320–330 (ref 37). Copyright 2018, with 
permission from Elsevier. (B, C) Design of a ligand decorated cell membrane mimetic 
surface for blood cell repellence and tumor cell capture. Reproduced from Li, T.; Li, N.; Ma, 
Y.; Bai, Y.-J.; Xing, C.-M.; Gong, Y.-K. J. Mater. Chem. B 2019, 7, 6087–6098 (ref 39), 
with permission of The Royal Society of Chemistry. (D) Capture strategy using Carpet Chip. 
Schematic of the CTC Carpet Chips connected in series. Rare CTCs were captured 
simultaneously from the peripheral blood of pancreatic cancer patients by using anti-
EpCAM and anti-CD133 antibodies in two different chips. Reproduced from Profiling 
Heterogeneous Circulating Tumor Cells (CTC) Populations in Pancreatic Cancer Using a 
Serial Microfluidic CTC Carpet Chip, Zeinali, M.; Murlidhar, V.; Fouladdel, S.; Shao, S.; 
Zhao, L.; Cameron, H.; Bankhead, A., III; Shi, J.; Cuneo, K. C.; Sahai, V.; Azizi, E.; Wicha, 
M. S.; Hafner, M.; Simeone, D. M.; Nagrath, S., Adv. Biosyst., Vol. 2, Issue 12 (ref 41). 
Copyright 2018 Wiley. (E) CTC Carpet Chip optimization with cell lines showing: (a) 
capture efficiency of cell lines with various levels of EpCAM expression, (b) an image 
showing dual CTC Carpet Chip, (c) capture efficiency of cancer cells spiked into blood with 
or without antibodies in the dual chips, (d) SEM image of the chip with captured cancer 
cells, and (e) confocal image of a CK+ cancer cells. Reproduced from Profiling 
Heterogeneous Circulating Tumor Cells (CTC) Populations in Pancreatic Cancer Using a 
Serial Microfluidic CTC Carpet Chip, Zeinali, M.; Murlidhar, V.; Fouladdel, S.; Shao, S.; 
Zhao, L.; Cameron, H.; Bankhead, A., III; Shi, J.; Cuneo, K. C.; Sahai, V.; Azizi, E.; Wicha, 
M. S.; Hafner, M.; Simeone, D. M.; Nagrath, S., Adv. Biosyst., Vol. 2, Issue 12 (ref 41). 
Copyright 2018 Wiley. (F) Circulating Plasma Cells (CPC) selection device: (a) schematic 
of the CPC selection device, (b) SEM image of the sinusoidal channels fabricated in a 
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thermoplastic, (c) image of DAPI stained affinity-selected RPMI-8226 cells, and (d) 
schematic of the CPCs selection process with anti-CD138 antibodies enzymatically cleaved 
following isolations thereby releasing intact cells. Reprinted from Isolation of Circulating 
Plasma Cells From Blood of Patients Diagnosed with Clonal Plasma Cell Disorders using 
Cell Selection Microfluidics, Integrative Biology, Vol. 10, Issue 2 (ref 42). Copyright 2018 
Oxford University Press.
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Acoustofluidic and acoustophoretic methods for cell sorting. (A) Sorting of PC3 cancer cells 
from WBCs. Following acoustic field activation, cancer cells are pushed toward the bottom 
collection outlet while the majority of the WBCs continue flowing to the waste outlet. 
Reproduced from Circulating Tumor Cell Phenotyping via High-Throughput Acoustic 
Separation, Wu, M.; Huang, P.-H.; Zhang, R.; Mao, Z.; Chen, C.; Kemeny, G.; Li, P.; Lee, A. 
V.; Gyanchandani, R.; Armstrong, A. J.; Dao, M.; Suresh, S.; Huang, T. J. Small, Vol. 14, 
Issue 32 (ref 51). Copyright 2018 Wiley. (B) 3D acoustofluidic tweezers (3D-AFT) sorting 
device. Particles are sorted to multiple outlets under the combined effects of acoustics and 
hydrodynamics. Reproduced from Wu, M.; Chen, K.; Yang, S.; Wang, Z.; Huang, P.-H.; 
Mai, J.; Li, Z.-Y.; Huang, T. J. Lab Chip 2018, 18, 3003–3010 (ref 52), with permission of 
The Royal Society of Chemistry. (C) Schematic of the acoustic flow cytometry system: (a) 
microfluidic device with collinearly aligned US transducer and laser focusing optical 
objective, (b) hydrodynamic 3D flow focusing in the microfluidic device, (c) magnified view 
of a collinearly aligned transducer and laser beam interacting with a particle and producing 
backscatter and PA waves, and (d) an experimental setup with the laser focused on the 
interrogation zone. Reproduced with permission from Gnyawali, V.; Strohm, E. M.; Wang, 
J.-Z.; Tsai, S. S. H.; Kolios, M. C.Sci Rep 2019, 9, 1585 (ref 53). Copyright 2019, Springer 
Nature. (D) Schematic of a multistage device for tumor cell isolation. The blood cells and 
tumor cells are collected from outlet A and outlet B. Reprinted from Sens. Actuators, B, Vol. 
258, Wang, K., Zhou, W., Lin, Z., Cai, F., Li, F., Wu, J., Meng, L., Niu, L., Zheng, H., 
Sorting of tumor cells in a microfluidic device by multistage surface acoustic waves, pp 
1174–1183 (ref 54) Copyright 2018, with permission from Elsevier. (E) Optical imaging 
indicated the positions of the regions (I–IV) for monitoring the distribution and trajectory of 
samples within the standing surface acoustic waves and traveling surface acoustic wave 
fields. Top right, finger pairs of the circular interdigital transducers; and bottom right, 
interdigital transducers on the substrate. Reprinted from Sens. Actuators, B, Vol. 258, Wang, 
Witek et al. Page 44













K., Zhou, W., Lin, Z., Cai, F., Li, F., Wu, J., Meng, L., Niu, L., Zheng, H., Sorting of tumor 
cells in a microfluidic device by multistage surface acoustic waves, pp 1174–1183 (ref 54) 
Copyright 2018, with permission from Elsevier. (F) CTCs sorting from PBMCs, when CTCs 
are of higher (a) and lower (b) acoustic impedance than that of PBMCs. Reproduced from 
Karthick, S.; Pradeep, P. N.; Kanchana, P.; Sen, A. K. Lab Chip 2018, 18, 3802–3813 (ref 
55), with permission of the Royal Society of Chemistry.
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(A) DLD device. (a) Cascading design with four active regions and five outlets for high-
resolution size-based cell sorting. (b) Device design considerations to improve sorting 
resolution including a wide theoretical cell fractioning unit with wide and long post arrays to 
introduce sorting corrections through redundancy, and buffer flow along outer walls to 
eliminate edge effects. Outlet resistances were COMSOL modeled to ensure vertical flow. 
(c) Evaluation of different pillar shapes in binary DLD devices and the effects of triangular 
and tumbling structures. Reproduced from Gomis, S.; Labib, M.; Coles, B. L. K.; van der 
Kooy, D.; Sargent, E. H.; Kelley, S. O. ACS Appl. Mater. Interfaces 2018, 10, 34811–34816 
(ref 81). Copyright 2018 American Chemical Society. (B) Diagram of the three different 
DLD device designs. Design 1: hydrodynamically focused particles form a single flow 
stream. Design 2: all particles move toward the outer channel wall followed by change in the 
direction of the micropillar array that results in displacement of only larger particles. Design 
3: combined principles used in designs 1 and 2. Reproduced from Xavier, M.; Holm, S. H.; 
Beech, J. P.; Spencer, D.; Tegenfeldt, J. O.; Oreffo, R. O. C.; Morgan, H. Lab Chip 2019, 19, 
513–523 (ref 82), with permission of The Royal Society of Chemistry. (C) (a) Schematic of 
a controlled incremental filtration device and (b) an assembled microfluidic module with 12 
multiplexed devices. Reprinted from Cytotherapy, Vol. 21, Strachan, B. C., Xia, H. U. I., 
Vörös, E., Gifford, S. C., Shevkoplyas, S. S., Improved expansion of T cells in culture when 
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isolated with an equipment-free, high-throughput, flow-through microfluidic module versus 
traditional density gradient centrifugation, pp 234–245 (ref 83). Copyright 2019, with 
permission from Elsevier. (D) Schematic of the CIF design with slanted posts and the 
direction of flow from top to bottom. Reprinted from Cytotherapy, Vol. 21, Strachan, B. C., 
Xia, H. U. I., Vörös, E., Gifford, S. C., Shevkoplyas, S. S., Improved expansion of T cells in 
culture when isolated with an equipment-free, high-throughput, flow-through microfluidic 
module versus traditional density gradient centrifugation, pp 234–245 (ref 83). Copyright 
2019, with permission from Elsevier. (E) CIF can operate in two ways: (a) hanging a bag 
with the input sample >5 ft above the module or (b) by compression of the sample bag with 
an infusion cuff. Reprinted from Cytotherapy, Vol. 21, Strachan, B. C., Xia, H. U. I., Vörös, 
E., Gifford, S. C., Shevkoplyas, S. S., Improved expansion of T cells in culture when 
isolated with an equipment-free, high-throughput, flow-through microfluidic module versus 
traditional density gradient centrifugation, pp. 234–245 (ref 83). Copyright 2019, with 
permission from Elsevier. (F) Schematic and (G) image of the inertial focusing-enhanced 
microfluidic system for cell processing. In this device, sorting of rare cells is accomplished 
by negative selection of prelabeled WBCs with immunomagnetic beads. First, the DLD 
device separates nucleated cells from RBC, platelets, and unbound magnetic beads. In the 
next step, the cells are accelerated through an inertial focusing device. The aligned tagged 
cells pass through a magnetic field where they are pushed toward the center of the channel. 
Remaining untagged cells are refocused in a second inertial focusing device and then 
entered a different region of the magnetic field leading to the removal of all labeled cells. 
Reproduced from Fachin, F.; Spuhler, P.; Martel-Foley, J. M.; Edd, J. F.; Barber, T. A.; 
Walsh, J.; Karabacak, M.; Pai, V.; Yu, M.; Smith, K.; Hwang, H.; Yang, J.; Shah, S.; 
Yarmush, R.; Sequist, L. V.; Stott, S. L.; Maheswaran, S.; Haber, D. A.; Kapur, R.; Toner, M. 
Sci. Rep., 2017, 7, 1–11 (ref 84). Copyright 2017 Springer Nature.
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(A) Mechatronic system (a) used to control cell ratcheting across the device. (b) 
Paramagnetic pillars patterned on a glass slide and (c) a flow cell. (d) The 1 μm particles 
moved across the ratchet and achieved a “critical pitch” at 40 μm pillar pitch. Reproduced 
from Murray, C.; Miwa, H.; Dhar, M.; Park, D. E.; Pao, E.; Martinez, J.; Kaanumale, S.; 
Loghin, E.; Graf, J.; Rhaddassi, K.; Kwok, W. W.; Hafler, D.; Puleo, C.; Di Carlo, D. Lab 
Chip 2018, 18, 2396–2409 (ref 30), with permission of The Royal Society of Chemistry. (B) 
Microfluidic device for MATE-seq. (a) The device integrated a DLD array and a droplet 
generator with inputs for barcoded cells-free pNPs mixture, buffer, oil, and lysis/RT-PCR 
mix, and outputs for the water-in-oil droplets and waste. (b) The barcoded cells and free 
pNPs were flowed in parallel with RT-PCR buffer (no mixing). (c) The barcoded cells after 
DLD were displaced toward the droplet generator (free pNPs removed). (d) Barcoded cells 
were encapsulated in droplets with lysis and RT-PCR mix. Reproduced from Ng, A. H. C.; 
Peng, S.; Xu, A. M.; Noh, W. J.; Guo, K.; Bethune, M. T.; Chour, W.; Choi, J.; Yang, S.; 
Baltimore, D.; Heath, J. R. Lab Chip 2019, 19, 3011–3021 (ref 17), with permission of The 
Royal Society of Chemistry. (C) Microfluidic utilizing giant magnetoresistance (GMR) 
integrated sensors. (a) Chip with microfluidic channel and storage chambers; (b) micrograph 
of the separation area inside the channel showing also the parallel conducting 
microstructures and the tapered conductors for the isolation of cells; and (c) micrograph of a 
chamber and quantification area including the GMR sensor, the conducting microstructure 
on top of the sensor for the attraction and magnetization of the MPs, and parallel conducting 
microstructures for manipulation of the magnetically labeled cancer cells. Reprinted from 
Sens. Actuators, B, Vol. 241, Kokkinis, G., Cardoso, S., Keplinger, F., Giouroudi, I., 
Microfluidic platform with integrated GMR sensors for quantification of cancer cells, pp 
438–445 (ref 88). Copyright 2017, with permission from Elsevier. (D) Schematic of 
microparticle distribution within the microfluidic using dual-neodymium magnet-based 
negative magnetophoresis. Reprinted from Kye, H. G.; Park, B. S.; Lee, J. M.; Song, M. G.; 
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Song, H. G.; Ahrberg, C. D.; Chung, B. G. Sci. Rep. 2019, p 9502 (ref 89). Copyright 2019 
Springer Nature. (E) Magnetizable micropipette tip for MACS, so-called “MACS-Tip” and 
standard operating procedure. Reprinted from Sens. Actuators, B, Vol. 272 Oh, S., Jung, Su 
H., Seo, H.,Min, M., Kim, B., Hahn, Y., Kang, J. H., Choi, S., Magnetic activated cell 
sorting (MACS) pipet tip for immunomagnetic bacteria separation, pp 324–330 (ref 24). 
Copyright 2018, with permission from Elsevier.
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(A) Schematic of a microfluidic cell sorter: (a) schematic of optical detection setup, (b) 
micrograph of sorter chip with jet flow generation chamber and microheaters, (c) illustration 
of the sorting method, red cells of interest were sorted with an upper jet flow generator into a 
lower outlet channel and green cells flowed to the waste, and (d) SEM of microheaters. 
Reproduced from de Wijs, K.; Liu, C.; Dusa, A.; Vercruysse, D.; Majeed, B.; Tezcan, D. S.; 
Blaszkiewicz, K.; Loo, J.; Lagae, L. Lab Chip 2017, 17, 1287–1296 (ref 94), with 
permission of The Royal Society of Chemistry. (B) Spark-generated microbubble cell sorter: 
(a) microfluidic for 3D hydrodynamic focusing and sorting. When a target sample passed 
through the laser spot, a spark discharge was triggered, and the cavitation microbubble 
deflected the identified sample into the collection channel, (b) photograph of the device, and 
(c) chip was composed of middle part made of stainless steel and the others were glass. 
Reproduced from Spark-generated microbubble cell sorter for microfluidic flow cytometry, 
Zhao, J.; You, Z., Cytometry A, 93, pp 222–231 (ref 95). Copyright 2018 Wiley. (C) 
Microfluidic sperm sorter: (a) photograph of the device made of PDMS and glass, (b) 
chambers A for sorting medium, B for semen seeding, and C for sperm collection, (c) 
medium flowing out from chamber A was supplied into chambers B and C, (d) 
microchannel network showing the junction area (red square). The 14 microchannels formed 
a laminar flow distribution into a crescent-shaped diffuser enabling more motile 
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spermatozoa to swim into this zone and travel the distance along the multiple microchannels. 
Reproduced from Nagata, M. P. B.; Endo, K.; Ogata, K.; Yamanaka, K.; Egashira, J.; 
Katafuchi, N.; Yamanouchi, T.; Matsuda, H.; Goto, Y.; Sakatani, M.; Hojo, T.; Nishizono, 
H.; Yotsushima, K.; Takenouchi, N.; Hashiyada, Y.; Yamashita, K. Proc. Natl. Acad. Sci. 
U.S.A., 115, pp E3087–E3096 (ref 98). Copyright 2018 National Academy of Sciences. (D) 
Microfluidic sorter for animal longitudinal CTC studies: (a) pump withdraws blood from an 
artery of a mouse and directs blood into a chip. CTC-depleted blood returns to the jugular 
vein of the mouse via a second cannula. (b) Top-view image of the microfluidic chip with 
valve actuation lines, (c) fluorescent CTC emits two pulses of light detected by a PMT. 
Computer-controlled pneumatic valves redirect fluorescent CTCs to a collection tube. A 
low-pass filter was applied to the raw data for identifying true peaks. (d) CTC sorting in real 
time, (e) enrichment of CTCs by a secondary sorting chip designed with a parallel channel 
to flush CTCs into wells containing lysis buffer. Reproduced from Hamza, B.; Ng, S. R.; 
Prakadan, S. M.; Delgado, F. F.; Chin, C. R.; King, E. M.; Yang, L. F.; Davidson, S. M.; 
DeGouveia, K. L.; Cermak, N.; Navia, A. W.; Winter, P. S.; Drake, R. S.; Tammela, T.; Li, 
C. M.-C.; Papagiannakopoulos, T.; Gupta, A. J.; Shaw Bagnall, J.; Knudsen, S. M.; Vander 
Heiden, M. G. et al. Proc. Natl. Acad. Sci. U.S.A. 116, pp 2232–2236 (ref 100). Copyright 
2019 National Academy of Sciences.
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(A) Diamagnetic droplet microfluidic: (a) sorting of cell-containing droplets from empty 
droplets, (b) size distinction between a particle-encapsulating droplet and empty droplets, (c) 
region of high magnetic field gradient with droplets deflected based on their size, (d) sorting 
of droplets into different reservoirs. Reproduced from Navi, M.; Abbasi, N.; Jeyhani, M.; 
Gnyawali, V.; Tsai, S. S. H. Lab Chip 2018, 18, 3361–3370 (ref 115), with permission of 
The Royal Society of Chemistry. (B) Fluorescence-activated droplet sorting (FADS) system: 
(a) micrograph of the acoustic sorting system and the view of the sorting region. Reproduced 
from Li, P.; Ma, Z.; Zhou, Y.; Collins, D. J.; Wang, Z.; Ai, Y. Anal. Chem. 2019, 91, 9970–
9977 (ref 116). Copyright 2019 American Chemical Society. (C) Schematic of a single-cell 
RT-PCR device integrating lysis and reagent addition. The device produced droplets ready 
for amplification. Cells were encapsulated with lysis buffer (a) and content mixed (b). 
Excess oil removed from the emulsion (c), and droplets packed for the incubation for a 
controlled time (d). Droplets with lysed-cells were merged with droplets containing PCR 
buffer for amplification (e). Cells expressing the target mRNA (f), yielded fluorescent 
TaqMan-positive signal (g). Reproduced from Kim, S. C.; Clark, I. C.; Shahi, P.; Abate, A. 
R. Anal. Chem. 2018, 90, 1273–1279 (ref 117). Copyright 2018 American Chemical 
Society. (D) Schematics of single-cell RT-LAMP assay using Sort N’ Merge platform: (a) 
droplets containing RT-LAMP reactants were generated, (b) droplets containing single-cell 
Witek et al. Page 52













and lysis buffer were generated and sorted into the storage device, (c) paired droplets were 
merged by electrohydrodynamic forces. RT-LAMP reaction performed followed by imaging-
based fluorescence measurements, (d) content of the droplets, and (e) principle of RT-LAMP 
reactions. Reproduced from Chung, M. T.; Kurabayashi, K.; Cai, D. Lab Chip 2019, 19, 
2425–2434 (ref 118) with permission of The Royal Society of Chemistry. (E) Droplet based 
platform for the screening of specific TCR T cells: (a) only specific TCR T cells are 
activated upon recognition of their cognate antigen, triggering the expression of eGFP and 
(b) schematic of the workflow. Droplets containing activated T cells were sorted for 
downstream molecular analysis. Reproduced from Segaliny, A. I.; Li, G.; Kong, L.; Ren, C.; 
Chen, X.; Wang, J. K.; Baltimore, D.; Wu, G.; Zhao, W. Lab Chip 2018, 18, 3733–3749 (ref 
119), with permission of The Royal Society of Chemistry. (F) Integrated digital-droplet 
microfluidic device and (a) view of multilayer construct of the device and (b) image of the 
device and the schema of operations. Reproduced from Ahmadi, F.; Samlali, K.; Vo, P. Q. 
N.; Shih, S. C. C. Lab Chip 2019, 19, 524–535 (ref 120), with permission of The Royal 
Society of Chemistry. (G) Digital detection of lambda DNA with three different 
concentrations of templates. Reproduced from Li, X.; Zhang, D.; Zhang, H.; Guan, Z.; Song, 
Y.; Liu, R.; Zhu, Z.; Yang, C. Anal. Chem. 2018, 90, 2570–2577 (ref 121). Copyright 2018 
American Chemical Society.
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(A) Wedge-shaped microfuidic chip: (a) overview and (b) dimensions of the microfuidic 
chip and (c) schematic diagram of CTC isolation using a wedge-shaped microchamber. 
Reproduced from Yang, C.; Zhang, N.; Wang, S.; Shi, D.; Zhang, C.; Liu, K.; Xiong, B. J. 
Transl. Med. 2018, 16, p 139 (ref 132). Copyright 2018 Springer Nature. (B) Microfluidic 
filter device: (a) schematic of device with two microporous membranes and (b) exploded 
view showing design of the chip with seven layers, including channel, vias, and two layers to 
seal the top and bottom of the device. Reproduced from Qiu, X.; Lombardo, J. A.; 
Westerhof, T. M.; Pennell, M.; Ng, A.; Alshetaiwi, H.; Luna, B. M.; Nelson, E. L.; 
Kessenbrock, K.; Hui, E. E.; Haun, J. B. Lab Chip 2018, 18, 2776–2786 (ref 133), with 
permission of The Royal Society of Chemistry. (C) “Confining” device: (a) microscopic 
image of the flow region containing two series of confining microchannels. The fluid flow is 
indicated by white arrows. (b) Concept of the elasticity-based cell classification; the position 
of a microbead inside the microchannels reflected its elasticity. Reproduced from Ren, J.; Li, 
J.; Li, Y.; Xiao, P.; Liu, Y.; Tsang, C. M.; Tsao, S. W.; Lau, D.; Chan, K. W. Y.; Lam, R. H. 
W. ACS Biomater. Sci. Eng. 2019, 5, 3889–3898 (ref 134). Copyright 2019 American 
Chemical Society. (D) Dual depth, lattice-shaped channel network for (a) particle sorting, 
(b) transport of particles in the lattice region, and (c, d) particle movement between shallow 
and deep channels and into the main channels. Reproduced from Yanai, T.; Ouchi, T.; 
Yamada, M.; Seki, M. Micromachines (Basel) 2019, 10 ( 6), 425 (ref 135). Coyright 2019 
The authors. (E) Pump-free cell trapping device bonded to a glass coverslip. Reproduced 
from Weng, L.; Ellett, F.; Edd, J.; Wong, K. H. K.; Uygun, K.; Irimia, D.; Stott, S. L.; Toner, 
M. Lab Chip 2017, 17, 4077–4088 (ref 136), with permission of The Royal Society of 
Chemistry. (F) Diagram showing the strategy for cell sorting based on the HDF scheme. 
Reproduced from Ozawa, R.; Iwadate, H.; Toyoda, H.; Yamada, M.; Seki, M. Lab Chip 
2019, 19, 1828–1837 (ref 137), with permission of The Royal Society of Chemistry.
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(A) Device utilizing DEP and hydrodynamic drag forces for cell sorting: (a) schematic of the 
concept of railing target cells (green) along a track (electrode) under pDEP and 
hydrodynamic drag and (b) fluorescence images of the tracks and the outlets during cell 
sorting. HCT116 cells (green) are sorted from 10 μm polystyrene beads (red). Reproduced 
from Xing, X.; Ng, C. N.; Chau, M. L.; Yobas, L. Lab Chip 2018, 18, 3760–3769 (ref 147), 
with permission of The Royal Society of Chemistry. (B) SEM images (a) of the device’s 
flow chamber and (b) a close-up view. Reproduced from Xing, X.; Ng, C. N.; Chau, M. L.; 
Yobas, L. Lab Chip 2018, 18, 3760–3769 (ref 147), with permission of The Royal Society of 
Chemistry. (C) Time-lapse images of yeast cells (a) rotational motions at the center of 
wireless electrodes (A = 5 V, f = 50 kHz). (b) Rotational motions at the center of wireless 
electrodes and in the center area where floating electrodes were absent (A = 5 V, f = 500 
kHz). (c) Clockwise rotation on their axes and propulsion around the wireless electrode 
edges (A = 5 V, f = 5 MHz). (d) Counterclockwise rotation on their axes and propulsion 
around wireless electrode edges (A = 5 V, f = 40 MHz). Reproduced from Wu, Y.; Ren, Y.; 
Tao, Y.; Hou, L.; Jiang, H. Anal. Chem. 2018, 90, 11461–11469 (ref 148). Copyright 2018 
American Chemical Society.
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(A) Dean flow fractionation device: (a) workflow for leukocyte impedance phenotyping for 
sample preprocessing, DFF leukocyte sorting, and impedance profiling, (b) image of the 
microfluidic chips, (c) optical image of single cells flowing through the electrodes in the 
detection region, and (d) measurement of multiple events from single cells. Reprinted from 
Biosens. Bioelectron., Vol. 118, Petchakup, C.; Tay, H. M.; Yeap, W. H.; Dalan, R.; Wong, 
S. C.; Li, K. H. H.; Hou, H. W. Label-free leukocyte sorting and impedance-based profiling 
for diabetes testing, pp 195–203 (ref 155). Copyright 2018, with permission from Elsevier. 
(B) Impedance profiling of different blood cell samples: (a) density scatter plot of cell size (|
ZLF|, V) versus opacity of diluted whole blood, PBMCs, DFF-sorted monocytes, DFF-sorted 
lymphocytes, and DFF-sorted neutrophils and (b) frequency distribution of different 
leukocyte subtypes. Reprinted from Biosens. Bioelectron., Vol. 118, Petchakup, C.; Tay, H. 
M.; Yeap, W. H.; Dalan, R.; Wong, S. C.; Li, K. H. H.; Hou, H. W. Label-free leukocyte 
sorting and impedance-based profiling for diabetes testing, pp 195–203 (ref 155). Copyright 
2018, with permission from Elsevier. (C) Sensing area showing a simple analytical 
expression for the lateral position measurement of the flowing particles (derived from the 
electrical signal, positions of the flowing particles, electrodes, and microchannel). 
Reproduced from Yang, D.; Ai, Y. Lab Chip 2019, 19, 3609–3617 (ref 156), with permission 
of The Royal Society of Chemistry. (D) Schematic of a microfluidic impedance cytometer 
showing impedance and fluorescence detection sections. The fluorescence from cells was 
measured simultaneously with impedance allowing direct correlation of electrical and 
fluorescent properties of single cells. Reproduced from Honrado, C.; Ciuffreda, L.; Spencer, 
D.; Ranford-Cartwright, L.; Morgan, H. J. R. Soc. Interface 2018, 15, 20180416 (ref 33), 
with permission of The Royal Society of Chemistry.
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(A) Microfluidic chip for CTC isolation and whole genome amplification: (a) chip consisted 
of 3 layers, the valve control channel, the sample processing channel, and glass substrate, (b) 
photograph and (c) an SEM of the blood-filtering segment, (d) enrichment segment, and (e) 
staining segment. (f) Photograph and SEM image of a subchannel, cell-processing 
chambers. (g–i) Operation of a tristate valve. Reproduced from Li, R.; Jia, F.; Zhang, W.; 
Shi, F.; Fang, Z.; Zhao, H.; Hu, Z.; Wei, Z. Lab Chip 2019, 19, 3168–3178 (ref 157), with 
permission of The Royal Society of Chemistry. (B) Integrated microfluidic Dean-flow 
fractionation device: (a) design of the device, (b) principle of operation of flow regulatory 
chip showing membrane deformation when fluidic pressures in the control channels were 
increased to push two elastic membranes toward the fluidic channel, and (c) principle of cell 
sorting. Reproduced from Zhang, X.; Zhu, Z.; Xiang, N.; Long, F.; Ni, Z. Anal. Chem. 2018, 
90, 4212–4220 (ref 158). Copyright 2018 American Chemical Society. (C) GAMA device: 
(a) view of the microfluidic device and an infusion apparatus connected to the input port, (b) 
valveless 10-channel device, a product from each channel is separately collected, (c) 
micrograph of the cell capture region, (d) 10-channel devices bonded to a glass silica wafer, 
(e) image of an intact and (f) lysed single cell, and fluorescence observed from YOYO-1 
stained genomic DNA. Reproduced from Tian, H. C.; Benitez, J. J.; Craighead, H. G. PLoS 
One 2018, 13, e0191520 (ref 14) with permission from PLOS.
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